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THIS	  THESIS	  IS	  BASED	  ON	  THE	  FOLLOWING	  THREE	  PAPERS:	  
Study	  I:	  	   Varnum	  C,	  Pedersen	  AB,	  Kjærsgaard-­‐Andersen	  P,	  
Overgaard	  S.	  Comparison	  of	  the	  risk	  of	  revision	  in	  
cementless	  total	  hip	  arthroplasty	  with	  ceramic-­‐on-­‐
ceramic	  and	  metal-­‐on-­‐polyethylene	  bearings.	  Acta	  
Orthop.	  2015;86(4):477-­‐84.	  
Study	  II:	  	   Varnum	  C,	  Pedersen	  AB,	  Makela	  K,	  Eskelinen	  A,	  Havelin	  
LI,	  Furnes	  O,	  Karrholm	  J,	  Garellick	  G,	  Overgaard	  S.	  
Increased	  risk	  of	  revision	  of	  cementless	  stemmed	  total	  
hip	  arthroplasty	  with	  metal-­‐on-­‐metal	  bearings.	  Acta	  
Orthop.	  2015;86(4):469-­‐76.	  
Study	  III:	  	  Varnum	  C,	  Pedersen	  AB,	  Kjærsgaard-­‐Andersen	  P,	  
Overgaard	  S.	  Do	  different	  types	  of	  bearings	  and	  noise	  
from	  total	  hip	  arthroplasty	  influence	  hip-­‐related	  pain,	  
function,	  and	  quality	  of	  life	  postoperatively?	  Acta	  
Orthop.	  2016	  Dec;87(6):567-­‐574.	  
	  
INTRODUCTION	  
Total	  hip	  arthroplasty	  
Total	  hip	  arthroplasty	  (THA)	  is	  a	  common	  and	  successful	  treatment	  
of	  patients	  suffering	  from	  severe	  osteoarthritis	  (OA)	  that	  
significantly	  reduces	  pain	  and	  improves	  hip	  function	  and	  quality	  of	  
life	  (QoL).	  It	  has	  been	  proclaimed	  that	  THA	  is	  the	  operation	  of	  the	  
century.2	  Historically	  in	  1923,	  Smith-­‐Petersen	  created	  a	  mould	  
arthroplasty	  made	  of	  glass	  to	  be	  inserted	  between	  the	  reshaped	  
articulating	  surfaces	  of	  the	  head	  of	  the	  femur	  and	  the	  acetabulum.	  
It	  was	  thought	  that	  the	  moulded	  glass	  would	  guide	  nature’s	  repair	  
of	  the	  defects	  in	  the	  cartilage.	  Due	  to	  the	  fragility	  of	  the	  material	  
used,	  the	  results	  were	  not	  encouraging,	  and	  in	  1938	  the	  first	  
vitallium	  mould	  arthroplasty	  was	  performed.3	  During	  the	  1950-­‐
60s,	  Sir	  John	  Charnley	  introduced	  the	  modern	  low	  torque	  friction	  
arthroplasty,	  which	  included	  the	  use	  of	  acrylic	  cement	  to	  fix	  
components	  to	  bone,	  high-­‐density	  polyethylene	  as	  bearing	  
material,	  and	  monoblock	  stem	  of	  metal.2,4	  Studies	  have	  reported	  
remarkable	  durability	  with	  77%5	  and	  81%6	  survivorship	  of	  these	  
THAs	  at	  25-­‐year	  follow-­‐up	  with	  any	  revision	  as	  endpoint,	  and	  the	  
concept	  is	  still	  the	  gold	  standard.	  
	  
Outcome	  of	  total	  hip	  arthroplasty	  
Traditionally,	  the	  outcome	  of	  THA	  (Figure	  1)	  has	  been	  evaluated	  
from	  the	  surgeon’s	  perspective.	  The	  surgeon-­‐based	  outcome	  may	  
be	  assessed	  in	  morbidity	  including	  peri-­‐	  and	  postoperative	  
complications.	  Surgical	  complications	  count	  bleeding,	  prosthetic	  
joint	  infection	  (PJI),	  damage	  to	  anatomical	  structures	  including	  
involvement	  of	  the	  sciatic	  nerve,	  dislocation,	  anisomelia,	  and	  
periprosthetic	  fracture,	  whereas	  medical	  complications	  include	  
pneumonia,	  deep	  venous	  thrombosis,	  and	  pulmonary	  embolism.	  
Also	  biomechanical	  reconstruction,	  range	  of	  motion,	  prosthetic	  
survival,	  causes	  of	  revision,	  and	  mortality	  are	  outcomes	  assessed	  
by	  the	  surgeon.	  	  
	   Furthermore,	  noises	  from	  the	  THA7	  and	  persistent	  hip-­‐related	  
pain	  have	  been	  used	  as	  outcome	  measures	  after	  THA.	  Studies	  have	  
shown,	  that	  persisting	  hip-­‐related	  pain	  was	  seen	  in	  28.1%	  of	  
patients	  12	  to	  18	  months	  after	  primary	  THA8,	  and	  that	  7%	  of	  
patients	  were	  dissatisfied	  or	  highly	  dissatisfied	  one	  year	  after	  
primary	  THA9.	  By	  including	  measures	  of	  pain,	  disability	  and	  
satisfaction	  into	  the	  definition	  of	  failure,	  a	  more	  balanced	  
assessment	  of	  outcome	  can	  be	  made,	  as	  patients	  and	  orthopaedic	  
surgeons	  may	  assess	  outcome	  after	  THA	  differently.	  Therefore,	  
	  
Figure	  1.	  Prognostic	  factors	  for	  the	  outcome	  of	  total	  hip	  
arthroplasty	  
	  
Outcomes	  of	  different	  bearings	  in	  total	  hip	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patient-­‐reported	  outcome	  measure	  (PROM),	  which	  can	  be	  disease-­‐
specific	  or	  generic,	  is	  recognized	  as	  a	  very	  important	  tool	  for	  
evaluating	  the	  outcome	  after	  THA.10,11	  The	  US	  Food	  and	  Drug	  
Administration	  (FDA)	  have	  defined	  a	  patient-­‐reported	  outcome	  
(PRO)	  as	  “any	  report	  of	  the	  status	  of	  a	  patient’s	  health	  condition	  
that	  comes	  directly	  from	  the	  patient,	  without	  interpretation	  of	  the	  
patient’s	  response	  by	  a	  clinician	  or	  anyone	  else”.12	  FDA	  strongly	  
recommends	  the	  use	  of	  PROs	  in	  clinical	  trials,	  and	  PROMs	  have	  
been	  implemented	  in	  national	  hip	  arthroplasty	  registries.10,13,14	  
Additionally,	  the	  economic	  outcome	  of	  THA	  may	  be	  assessed.15	  
	   The	  outcome	  after	  THA	  may	  be	  influenced	  by	  a	  number	  of	  
prognostic	  factors,	  which	  may	  be	  related	  to	  the	  patient,	  treatment,	  
and	  structure	  (Figure	  1).	  Prognostic	  factors	  may	  be	  categorised	  
into	  non-­‐modifiable,	  e.g.	  sex	  and	  age,	  and	  modifiable,	  e.g.	  alcohol	  
consumption,	  smoking	  habits,	  and	  activity	  level.	  Previous	  literature	  
has	  shown	  that	  the	  patient-­‐related	  factors	  sex,	  age,	  diagnosis,	  
comorbitity,	  and	  use	  of	  medication	  influence	  the	  outcome	  of	  
THA.16-­‐23	  The	  outcome	  may	  also	  be	  affected	  by	  the	  surgical	  
approach,	  implant	  design,	  fixation,	  type	  of	  bearings,	  and	  femoral	  
head	  size.21,24-­‐31	  Furthermore,	  hospital	  volume	  and	  fast-­‐track	  set-­‐
up	  may	  be	  of	  importance	  for	  the	  outcome	  of	  THA.32,33	  Among	  all	  
these	  determinants	  of	  the	  outcome	  of	  THA,	  the	  focus	  of	  this	  thesis	  
is	  different	  types	  of	  bearings.	  
	  
Types	  of	  bearings	  
Metal-­‐on-­‐polyethylene	  bearings	  
Metal-­‐on-­‐polyethylene	  (MoP),	  a	  femoral	  head	  of	  stainless	  steel	  
articulating	  on	  a	  polyethylene	  acetabular	  liner,	  are	  by	  far	  the	  most	  
commonly	  used	  bearings	  in	  THA	  and	  are	  therefore	  considered	  the	  
“standard”	  bearings.	  The	  major	  concern	  related	  to	  the	  use	  of	  MoP	  
bearings	  is	  wear	  and	  generation	  of	  polyethylene	  wear	  particles	  
which	  potentially	  can	  lead	  to	  osteolysis	  and	  aseptic	  loosening	  of	  
the	  implant.	  Aseptic	  loosening	  is	  the	  most	  prevalent	  cause	  of	  
revision	  accounting	  for	  51.8%	  of	  registered	  revisions	  in	  the	  Danish	  
Hip	  Arthroplasty	  Registry	  (DHR).16	  
	   Generation	  of	  polyethylene	  wear	  particles	  can	  primarily	  result	  
from	  three	  different	  processes:	  Abrasion	  (a	  harder	  surface	  make	  
grooves	  in	  a	  softer	  material),	  adhesion	  (formation	  of	  a	  transfer	  film	  
occurring	  when	  a	  softer	  material	  is	  smeared	  onto	  a	  harder	  
surface),	  and	  fatigue	  (generation	  of	  particles	  resulting	  from	  
subsurface	  cracks).34	  Wear	  particles	  can	  be	  found	  in	  periprosthetic	  
osteolytic	  lesions	  embedded	  in	  a	  membrane	  also	  containing	  
macrophages	  which	  release	  pro-­‐inflammatory	  mediators	  when	  
having	  phagocytized	  ultrahigh-­‐molecular-­‐weight	  polyethylene	  
(UHMWPE)	  wear	  particles.	  Consequently,	  osteoclasts	  are	  activated	  
to	  resorb	  the	  bone	  at	  the	  bone-­‐implant	  interface	  that	  can	  result	  in	  
painful	  loosening	  of	  the	  implant.35-­‐40	  Previous	  research	  has	  stated	  
that	  linear	  polyethylene	  wear	  exceeding	  0.2	  mm/year	  or	  
volumetric	  wear	  surpassing	  150	  mm3/year	  predisposes	  to	  
periprosthetic	  osteolysis.41	  
	   In	  cementless	  MoP	  THA,	  the	  polyethylene	  liner	  is	  inserted	  
into	  a	  metal	  acetabular	  shell	  leading	  to	  both	  frontside	  and	  
backside	  wear.	  Ex	  vivo,	  however,	  linear	  and	  volumetric	  wear	  from	  
the	  articulating	  side	  were	  at	  least	  three	  orders	  of	  magnitude	  
higher	  than	  the	  wear	  estimates	  at	  the	  backside.	  This	  variation	  was	  
mainly	  explained	  by	  the	  difference	  in	  maximum	  sliding	  distance	  at	  
the	  articulating	  surfaces	  (measured	  in	  mm)	  compared	  to	  the	  back	  
surface	  (measured	  in	  μm).42	  	  
	   In	  order	  to	  reduce	  abrasive/adhesive	  and	  fatigue	  wear,	  much	  
effort	  has	  been	  made	  to	  improve	  the	  tribological	  properties	  of	  
polyethylene	  during	  the	  last	  decades.	  Charnley	  introduced	  the	  
polytetrafluorethylene	  (Teflon)	  as	  material	  for	  the	  acetabular	  
component	  but	  due	  to	  poor	  wear	  resistance,	  this	  material	  was	  
abandoned	  in	  favour	  of	  high	  molecular	  weight	  polyethylene.4,43	  
Charnley	  recommended	  the	  use	  of	  gamma	  sterilization	  for	  
polyethylene	  components,	  a	  technique	  that	  is	  still	  used.44	  In	  hip	  
simulators,	  wear	  rates	  decreased	  by	  a	  factor	  of	  more	  than	  30	  
when	  the	  molecular	  weight	  of	  polyethylene	  increased	  from	  5x105	  
to	  2x106,	  and	  a	  single	  dose	  of	  gamma	  irradiation	  at	  2.5-­‐5.0	  Mrad	  (1	  
Mrad=10	  kGy)	  progressively	  improved	  the	  wear	  resistance	  in	  
UHMWPE.45	  A	  drawback	  of	  gamma	  irradiation	  in	  air	  is,	  that	  it	  leads	  
to	  long-­‐lived	  free	  radicals	  which	  react	  with	  oxygen	  resulting	  in	  
progressive	  oxidation	  and	  deterioration	  of	  the	  mechanical	  
properties	  of	  the	  polymer.46	  In	  order	  to	  reduce	  oxidative	  
degradation,	  some	  manufacturers	  started	  to	  gas-­‐sterilize	  by	  
ethylene	  oxide	  or	  gas	  plasma	  but	  in	  contrast	  to	  gamma	  irradiation,	  
these	  alternative	  gas-­‐sterilization	  methods	  did	  not	  cross-­‐link	  the	  
polyethylene.47	  In	  a	  radiographic	  wear	  study,	  higher	  wear	  rates	  
was	  found	  for	  uncross-­‐linked,	  gas-­‐sterilized	  components	  when	  
compared	  with	  gamma-­‐sterilized	  controls.48	  Furthermore	  it	  was	  
confirmed	  that,	  in	  hip	  simulator	  testing,	  elevated	  doses	  of	  
irradiation	  cross-­‐linking	  reduced	  wear	  rates,	  and	  thermal	  
processing	  after	  irradiation	  influenced	  the	  mechanical	  properties	  
and	  oxidative	  resistance.	  Irradiation	  cross-­‐linking,	  whether	  by	  
gamma	  or	  electron	  irradiation,	  when	  combined	  with	  annealing	  and	  
remelting	  thermal	  treatments	  resulted,	  in	  the	  late	  1990s,	  in	  the	  
first	  generation	  of	  highly	  cross-­‐linked	  polyethylene	  (HXLPE).44,49,50	  	  
	   Starting	  around	  2005,	  the	  newer	  generations	  of	  HXLPE	  were	  
developed	  by	  the	  use	  of	  different	  methods	  to	  stabilize	  the	  
polymer:	  Sequential	  irradiation	  and	  annealing	  process	  whereby	  
the	  polyethylene	  receives	  a	  high	  dosage	  of	  radiation	  cumulatively	  
instead	  of	  during	  one	  event	  (X3	  material)51;	  solid-­‐state,	  hydrostatic	  
extrusion	  that	  modify	  the	  physical	  and	  mechanical	  properties	  of	  
HXLPE	  by	  induction	  of	  plastic	  deformation	  and	  orientation	  of	  the	  
molecules	  (ArCom	  XL	  material)52;	  and	  incorporation	  of	  vitamin	  E	  
(α-­‐Tocopherol),	  which	  react	  with	  peroxy	  free	  radicals	  on	  lipid	  




Ceramic-­‐on-­‐ceramic	  (CoC)	  bearings	  were	  introduced	  to	  reduce	  
wear	  debris.	  In	  1970,	  Boutin	  implanted	  the	  first	  THA	  with	  all-­‐
alumina	  bearings	  in	  France.54	  Today’s	  ceramic	  bearings	  consist	  of	  
aluminium	  oxide	  (alumina,	  Al2O3),	  zirconium	  oxide	  (zirconia,	  ZrO2)	  
or	  composites	  and	  have	  been	  changed	  in	  order	  to	  reduce	  fracture	  
risk.	  The	  first	  generation	  alumina	  had	  low	  density	  and	  a	  very	  
coarse	  microstructure,	  whereas	  the	  newer	  third	  generation	  had	  a	  
higher	  purity	  and	  a	  finer	  grain	  structure	  and	  was	  hot	  isostatic	  
pressed,	  laser	  engraved,	  and	  proof	  tested.55	  Alumina	  has	  been	  
used	  for	  CoC	  bearings.56-­‐58	  The	  safety	  of	  a	  ceramic	  component	  is	  
correlated	  to	  its	  mechanical	  strength,	  and	  efforts	  for	  improving	  
this	  strength	  have	  been	  made	  by	  developing	  different	  
manufacturing	  processes.	  
	   Zirconia	  ceramic	  is	  used	  in	  the	  form	  of	  yttria	  stabalized	  
tetragonal	  zirconia	  polycrystals	  (Y-­‐TZP)	  to	  impede	  the	  
hydrothermal	  degradation	  of	  zirconia.	  Y-­‐TZP	  has	  a	  higher	  density	  
and	  finer	  grain	  size	  than	  alumina,	  providing	  about	  double	  its	  
fracture	  toughness	  and	  flexural	  strength.	  There	  is	  clear	  
experimental	  evidence	  that	  the	  wear	  rate	  of	  zirconia-­‐on-­‐zirconia	  
bearings	  is	  too	  high	  to	  use	  in	  prosthetic	  joints,	  and	  zirconia	  is	  
traditionally	  used	  for	  the	  femoral	  head	  in	  combination	  with	  an	  
UHMWPE	  acetabular	  liner.59,60	  
	   Two	  different	  composites	  can	  be	  made	  from	  alumina	  and	  
zirconia:	  A	  zirconia	  matrix	  reinforced	  with	  alumina	  particles	  
(alumina-­‐toughened	  zirconia)	  or	  an	  alumina	  matrix	  reinforced	  with	  
zirconia	  particles	  (zirconia-­‐toughened	  alumina,	  ZTA).	  The	  hardness	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of	  ZTA	  composites	  is	  greater	  resulting	  in	  higher	  wear	  resistance.	  
With	  new	  processing	  techniques,	  it	  is	  possible	  to	  obtain	  high-­‐
density	  ZTA	  nanocomposites	  with	  a	  very	  homogeneous	  
microstructure,	  nearly	  the	  same	  hardness	  as	  alumina,	  a	  higher	  
fracture	  toughness,	  high	  hydrothermal	  stability,	  and	  high	  crack-­‐
resistance.61,62	  
	   The	  most	  frequently	  used	  ceramic	  materials	  today	  in	  THA	  are	  
the	  third	  generation	  hot	  isostatic	  pressed	  alumina	  commercially	  
known	  as	  BIOLOX	  forte	  and	  the	  fourth	  generation	  commercially	  
known	  as	  BIOLOX	  delta,	  which	  is	  an	  alumina	  matrix	  composite	  
comprised	  of	  75%	  alumina,	  24%	  zirconia,	  and	  1%	  elongated	  oxides	  
of	  chromium	  and	  strontium.63	  Some	  of	  the	  advantages	  with	  the	  
use	  of	  CoC	  bearings	  are	  the	  low	  wear	  rates	  both	  ex	  vivo	  and	  in	  
vivo.63-­‐66	  In	  addition,	  wear	  debris	  produced	  from	  CoC	  bearings	  are	  
less	  biologically	  active	  than	  metal	  or	  polyethylene	  debris.67,68	  The	  
major	  concerns	  related	  to	  the	  use	  of	  CoC	  bearings	  are	  fracture	  of	  
the	  ceramic	  components69-­‐73	  and	  squeaking	  and	  other	  noises7,74,75.	  
Also,	  the	  sandwich	  design	  for	  ceramic	  inserts	  have	  been	  reported	  
to	  have	  problems	  in	  terms	  of	  dislodging	  of	  the	  ceramic	  insert.76,77	  
	  
Metal-­‐on-­‐metal	  bearings	  
In	  1938,	  Wiles	  performed	  the	  first	  THA	  consisting	  of	  pre-­‐formed	  
acetabulum	  and	  femoral	  head	  made	  of	  stainless	  steel	  attaching	  it	  
to	  bone	  with	  bolts	  and	  screws.1	  During	  the	  beginning	  of	  the	  1960s,	  
McKee	  and	  Watson-­‐Farrar	  implanted	  THAs	  with	  metal-­‐on-­‐metal	  
(MoM)	  bearings.	  The	  components	  were	  constructed	  of	  chromium-­‐
cobalt	  alloy	  and	  fixed	  to	  the	  bone	  by	  methylmethracrylate.78	  In	  the	  
same	  period,	  Ring	  developed	  a	  screw	  fixated	  cup	  to	  be	  used	  with	  
the	  Moore’s	  prosthesis.79	  By	  mid-­‐1970s,	  MoM	  articulations	  were	  
abandoned	  in	  favour	  of	  Charnley’s	  technique.80	  Modified	  alloys	  
marked	  a	  new	  era	  for	  MoM	  bearings,	  and	  in	  1988	  Weber	  
implanted	  the	  first	  MoM	  THA	  with	  Metasul	  bearings	  manufactured	  
from	  carbon	  rich	  cobalt	  chromium	  molybdenum	  alloy81,82,	  and	  the	  
Metasul	  bearings	  are	  still	  used	  today.	  The	  current	  MoM	  implants	  
are	  made	  of	  a	  Cobalt-­‐28	  Chromium-­‐6	  Molybdenum	  Alloy	  (ASTM	  
(American	  Society	  for	  Testing	  and	  Materials)	  F75	  or	  ASTM	  F1537)	  
and	  have	  a	  high	  carbon	  content	  above	  0.20%	  which	  has	  the	  
purpose	  of	  decreasing	  wear83.	  
	   With	  the	  reintroduction	  of	  MoM	  bearings	  it	  was	  possible	  to	  
use	  large-­‐diameter-­‐heads	  (LDHs)	  which	  were	  shown	  to	  reduce	  
wear	  ex	  vivo.84	  Ex	  vivo,	  LDHs	  have	  been	  shown	  to	  improve	  range	  of	  
motion	  (ROM)	  and,	  due	  to	  increased	  jump	  distance	  (the	  distance	  a	  
femoral	  head	  requires	  for	  displacement	  from	  the	  acetabular	  cup	  
before	  dislocation),	  decrease	  the	  component-­‐to-­‐component	  
impingement	  and	  hereby	  the	  potential	  risk	  of	  dislocation.85	  
However,	  a	  randomised	  clinical	  trial	  have	  shown	  no	  difference	  in	  
total	  ROM	  for	  patients	  with	  LDH	  and	  hip	  resurfacing	  arthroplasty	  
compared	  to	  patients	  having	  28-­‐mm	  femoral	  head.86	  In	  a	  study	  
from	  the	  Finnish	  Hip	  Arthroplasty	  Register,	  a	  decreased	  risk	  of	  
revision	  due	  to	  dislocation	  was	  found,	  when	  comparing	  32-­‐36	  mm	  
and	  femoral	  heads	  larger	  than	  36	  mm	  to	  28	  mm	  heads.29	  
	   The	  most	  important	  predictor	  of	  the	  wear	  rate	  in	  MoM	  
bearings	  is	  edge-­‐loading87,	  and	  the	  chromium	  and	  cobalt	  wear	  
particles	  may	  result	  in	  different	  periprosthetic	  soft-­‐tissue	  lesions:	  
metallosis88,	  aseptic	  lymphocytic	  vasculitis-­‐associated	  lesions	  
(ALVAL)89,	  pseudotumours90	  and	  adverse	  reaction	  to	  metal	  debris	  
(ARMD)91.	  Metallosis	  is	  the	  gross	  staining	  of	  the	  periprosthetic	  soft	  
tissue	  as	  a	  result	  of	  metal	  deposition	  and	  is	  seen	  at	  revision	  
surgery.	  ALVAL	  is	  characterized	  by	  a	  diffuse	  and	  perivascular	  
infiltrate	  of	  T-­‐	  and	  B-­‐lymphocytes	  and	  plasma	  cells,	  high	  
endothelial	  venules,	  massive	  fibrin	  exudation,	  accumulation	  of	  
macrophages,	  infiltrates	  of	  eosinophils,	  and	  necrosis	  and	  was	  
found	  in	  periprosthetic	  tissues	  from	  patients	  with	  failed	  MoM	  	  
Figure	  2.	  A	  ball-­‐and-­‐cup	  arthroplasty	  performed	  in	  1938.	  
Radiograph	  13	  years	  later1	  
	  
	  
bearings.89	  Pseudotumours	  are	  symptomatic	  reactive	  
periprosthetic	  soft	  tissue	  changes	  demonstrated	  on	  magnetic	  
resonance	  imaging	  (MRI)	  as	  thin-­‐	  or	  thick-­‐walled	  cysts	  or	  solid	  
masses,	  and	  their	  histology	  resembles	  that	  of	  ALVAL,	  but	  a	  more	  
diffuse	  lymphocytic	  infiltrate	  as	  well	  as	  extensive	  connective	  tissue	  
necrosis	  characterise	  pseudotumours.90,92	  ARMD	  is	  used	  as	  an	  
umbrella	  term	  and	  describes	  joint	  failures	  associated	  with	  pain,	  
large	  sterile	  effusions	  of	  the	  hip	  and/or	  macroscopic	  
metallosis/necrosis,	  thus	  including	  metallosis,	  ALVAL	  and	  
pseudotumours.91	  
	   Apart	  from	  the	  local	  reactions,	  also	  systemic	  effects	  might	  be	  
seen.	  Systemic	  cobalt	  toxicity	  have	  been	  described	  following	  
revision	  of	  fractured	  ceramic	  bearings	  and	  in	  patients	  with	  failed	  
MoM	  implants,	  and	  possible	  symptoms	  include	  impairment	  of	  
vision	  and	  hearing,	  hypothyroidism,	  peripheral	  neuropathy,	  
cardiomyopathy,	  depression,	  anxiety,	  tinnitus,	  fatigue,	  and	  
anorexia.93-­‐99	  There	  is	  dissemination	  of	  cobalt	  and	  chromium	  to	  
sites	  distant	  to	  the	  orthopaedic	  implant.100	  It	  has	  been	  found,	  that	  
patients	  having	  THA	  have	  a	  significant	  increase	  of	  chromosomal	  
damage	  in	  peripheral	  blood	  lymphocytes,	  and	  that	  the	  changes	  
may	  depend	  in	  part	  on	  the	  type	  of	  prosthesis.101	  However,	  the	  
incidence	  of	  cancer	  after	  THA	  is	  low	  predicted	  from	  the	  normal	  
population,	  and	  the	  overall	  risk	  of	  cancer	  is	  not	  higher	  for	  MoM	  
than	  for	  any	  other	  type	  of	  bearings.	  The	  low	  risk	  of	  cancer	  must	  be	  




In	  order	  to	  improve	  the	  outcome	  after	  THA,	  this	  PhD	  study	  was	  
initiated.	  Although	  improvements	  of	  the	  polyethylene	  in	  MoP	  
bearings,	  alternative	  bearings	  such	  as	  CoC	  and	  MoM	  have	  been	  
used	  in	  THA,	  which	  may	  result	  in	  better	  implant	  survival	  and	  PRO.	  
Only	  a	  few	  registry-­‐based	  studies	  on	  CoC	  and	  stemmed	  MoM	  THA	  
have	  been	  published.28,104-­‐107	  These	  studies	  may	  be	  hampered	  by	  
the	  lack	  of	  information	  on	  completeness	  of	  data,	  of	  examination	  of	  
!
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implant	  types,	  and	  of	  causes	  of	  revision	  and	  may	  be	  limited	  by	  the	  
short	  follow-­‐up	  and	  the	  used	  statistical	  methods	  including	  lack	  of	  
adjustments	  for	  confounders.	  Moreover,	  the	  existing	  literature	  on	  
implant	  survival	  and	  PRO	  including	  information	  on	  hip-­‐related	  
noises	  from	  patients	  having	  MoP,	  CoC	  or	  MoM	  THA	  represents	  
smaller	  series	  of	  patients	  involving	  one	  to	  few	  hospitals	  and	  
clinics.7,24,27,108-­‐112	  These	  studies	  are	  limited	  by	  the	  small	  sample	  
size,	  and	  results	  from	  a	  single	  institution	  may	  reduce	  the	  
generalizability	  of	  the	  findings.	  Furthermore,	  the	  results	  may	  be	  
biased,	  as	  some	  authors	  have	  been	  involved	  in	  the	  development	  of	  
the	  implant.	  To	  overcome	  these	  issues,	  we	  decided	  to	  perform	  
nation-­‐wide,	  population-­‐based	  studies,	  which	  can	  take	  patient-­‐	  
and	  surgery-­‐related	  characteristics	  into	  account,	  in	  order	  to	  
provide	  patients	  the	  optimal	  type	  of	  bearings	  in	  THA.	  
	  
AIMS	  OF	  THE	  THESIS	  
The	  aims	  of	  this	  thesis	  were:	  
	   Study	  I:	  To	  examine	  the	  revision	  risk	  and	  to	  investigate	  the	  
causes	  of	  revision	  of	  cementless	  CoC	  THAs	  comparing	  them	  to	  
those	  of	  “standard”	  MoP	  THAs.	  
	   Study	  II:	  To	  compare	  the	  six-­‐year	  revision	  risk	  for	  MoM	  
bearings	  with	  that	  for	  MoP	  bearings	  in	  cementless	  stemmed	  THA,	  
and	  further	  to	  study	  the	  revision	  risk	  for	  different	  designs	  of	  
stemmed	  MoM	  THAs	  and	  the	  causes	  of	  revision.	  
	   Study	  III:	  To	  examine	  the	  association	  between	  CoC,	  MoM,	  and	  
MoP	  bearings	  and	  both	  generic	  and	  disease-­‐specific	  PROMs,	  and	  
furthermore	  to	  examine	  the	  incidence	  and	  types	  of	  noises	  from	  





The	  literature	  search	  was	  not	  based	  on	  a	  systematic	  review.	  It	  was	  
conducted	  throughout	  the	  study	  period	  with	  a	  final	  search	  in	  
January	  2016.	  PubMed	  was	  the	  main	  database	  for	  literature	  
search,	  and	  the	  medical	  subject	  heading	  (MeSH)	  “Total	  hip	  
replacement”	  was	  combined	  with	  the	  following	  keywords:	  
“ceramic-­‐on-­‐ceramic”,	  “alumina	  bearings”,	  “metal-­‐on-­‐metal”,	  
“polyethylene”,	  “HOOS”,	  “EQ-­‐5D”,	  “UCLA”,	  and	  “satisfaction”.	  Also	  
the	  reference	  lists	  of	  relevant	  articles	  and	  annual	  reports	  from	  
national	  hip	  arthroplasty	  registries	  were	  reviewed.	  Furthermore,	  
the	  Web	  of	  Science	  database	  was	  used	  to	  search	  for	  specific	  
articles.	  The	  literature	  search	  was	  limited	  to	  articles	  in	  English	  or	  
Danish	  and	  mainly	  to	  articles	  published	  from	  2005	  and	  onwards,	  
although	  some	  key	  articles	  from	  before	  2005	  have	  been	  included	  
due	  to	  historical	  interest.	  	  
	  
Data	  sources	  
The	  Civil	  Registration	  System	  (study	  I-­‐III)	  
Since	  the	  establishment	  in	  1968,	  the	  Civil	  Registration	  System	  
(CRS)	  has	  contained	  individual	  information	  on	  the	  unique	  10-­‐digit	  
identification	  number	  issued	  to	  all	  Danish	  citizens	  at	  birth.	  This	  
personal	  identification	  number	  encodes	  for	  date	  of	  birth	  and	  sex	  
and	  allows	  for	  individual-­‐level	  linkage	  between	  Danish	  data	  
sources.	  Moreover,	  the	  CRS	  contains	  information	  on	  address,	  
protection	  against	  inquiry	  from	  researchers,	  and	  continuously	  
updated	  information	  on	  migration	  and	  vital	  status	  including	  date	  
of	  death.	  The	  CRS	  is	  virtually	  complete,	  since	  the	  prevalence	  of	  
disappeared	  persons	  is	  around	  0.3%.	  This	  ensures	  complete	  
follow-­‐up	  in	  Danish	  cohort	  studies	  when	  using	  CRS	  data	  for	  
censoring.113	  
	  
The	  Danish	  Hip	  Arthroplasty	  Registry	  (study	  I-­‐III)	  
The	  DHR	  was	  established	  January	  1,	  1995	  with	  the	  aim	  of	  
registering	  and	  improving	  the	  results	  after	  THA	  in	  Denmark.114	  
During	  1995	  to	  2014,	  approximately	  140,000	  primary	  THAs	  and	  
22,000	  revisions	  have	  been	  reported	  to	  the	  DHR.	  The	  coverage	  is	  
very	  high	  and	  in	  2014,	  28	  orthopaedic	  departments	  and	  16	  private	  
clinics	  reported	  to	  the	  DHR,	  and	  the	  completeness	  has	  been	  about	  
95%	  for	  both	  primary	  procedures	  and	  revisions	  during	  the	  last	  
many	  years	  compared	  to	  the	  Danish	  National	  Patient	  Registry	  
(DNPR).16	  The	  authorities	  reimburse	  the	  orthopaedic	  departments	  
when	  reporting	  to	  the	  DNPR;	  therefore,	  reporting	  to	  the	  DNPR	  is	  
considered	  the	  gold	  standard.	  Clinical	  data	  on	  primary	  THAs,	  
revisions,	  and	  at	  follow-­‐up	  examinations	  are	  prospectively	  
collected.	  Preoperative	  data	  include	  the	  unique	  personal	  
identification	  number,	  hospital	  code,	  laterality	  of	  the	  affected	  hip,	  
previous	  surgery	  in	  the	  same	  hip,	  function	  of	  walking	  according	  to	  
Charnley’s	  groups	  A,	  B,	  and	  C115,	  and	  diagnosis.	  In	  addition,	  it	  is	  
possible	  to	  register	  the	  preoperative	  Harris	  Hip	  Score	  (HHS)116,	  but	  
this	  is	  not	  compulsory.	  The	  perioperative	  data	  registered	  in	  the	  
DHR	  include	  the	  date	  of	  surgery;	  antibiotic	  and	  thromboembolic	  
prophylaxis;	  type	  of	  anaesthesia;	  duration	  of	  surgery;	  type	  of	  
acetabular	  and	  femoral	  component	  and	  their	  fixation;	  
complications	  in	  the	  acetabulum	  and	  the	  femur;	  and	  type,	  size,	  
and	  material	  of	  the	  prosthetic	  femoral	  head	  and	  the	  acetabular	  
liner.	  For	  revisions,	  defined	  as	  a	  new	  surgical	  procedure	  including	  
complete	  or	  partial	  exchange	  or	  removal	  of	  the	  prosthetic	  
components,	  the	  following	  is	  registered:	  Indication,	  prosthetic	  
status	  before	  revision,	  extent	  of	  revision,	  number	  of	  earlier	  
revisions,	  and	  classification	  of	  acetabular	  and	  femoral	  bone	  loss.	  
Data	  collected	  at	  follow-­‐up	  include	  the	  laterality	  of	  the	  hip,	  date	  of	  
the	  latest	  surgery,	  date	  of	  follow-­‐up	  examination,	  postoperative	  
complications,	  the	  patient’s	  assessment	  of	  satisfaction	  with	  the	  
primary	  or	  revision	  THA,	  and	  possibly	  the	  HHS.	  As	  there	  are	  no	  
national	  guidelines	  for	  postoperative	  follow-­‐up	  after	  primary	  THA	  
or	  revisions,	  postoperative	  follow-­‐up	  data	  is	  registered	  at	  different	  
time	  points	  for	  the	  different	  departments.	  	  
	   The	  completeness	  for	  both	  primary	  THAs	  and	  revisions	  is	  
validated	  yearly	  in	  the	  annual	  reports,	  and	  data	  on	  diagnosis	  for	  
primary	  THA	  and	  postoperative	  complications117	  and	  on	  deep	  PJI	  
as	  cause	  of	  revision118	  has	  been	  validated.	  But	  no	  validation	  of	  the	  
data	  on	  prosthetic	  components	  including	  material	  of	  the	  
acetabular	  liner	  and	  the	  femoral	  head	  has	  been	  made.	  	  
	  
The	  Nordic	  Arthroplasty	  Register	  Association	  (study	  II)	  
To	  obtain	  a	  larger	  study	  population,	  data	  from	  the	  Nordic	  
Arthroplasty	  Register	  Association119	  (NARA)	  was	  used	  in	  study	  II.	  
Hip	  arthroplasty	  registries	  were	  established	  in	  Sweden	  in	  1979,	  in	  
Finland	  in	  1980,	  and	  in	  Norway	  in	  1987.120-­‐122	  In	  2007,	  selected	  
individual	  data	  on	  each	  THA	  registered	  in	  the	  arthroplasty	  
registries	  in	  Denmark,	  Norway,	  and	  Sweden	  were	  merged	  into	  the	  
NARA	  database,	  and	  Finland	  were	  able	  to	  deliver	  data	  in	  2010.123	  
Data	  in	  the	  four	  registries	  were	  not	  fully	  compatible	  as	  there	  were	  
some	  differences	  in	  variables	  and	  in	  the	  definition	  of	  these.	  
Therefore,	  a	  common	  dataset	  including	  data	  that	  all	  registries	  
were	  able	  to	  deliver	  were	  defined,	  and	  consensus	  has	  been	  made	  
according	  to	  definition	  of	  several	  variables.	  In	  each	  national	  
registry,	  the	  selected	  data	  were	  anonymised,	  including	  deletion	  of	  
the	  national	  civil	  registration	  number,	  before	  merging	  into	  the	  
common	  NARA	  database.124	  Thus,	  identification	  of	  patients	  at	  an	  
individual	  level	  was	  not	  possible.	  As	  a	  consequence,	  the	  
completeness	  and	  quality	  of	  data	  in	  the	  NARA	  database	  depend	  on	  
the	  completeness	  and	  quality	  of	  data	  in	  each	  of	  the	  four	  national	  
registries.	  Although	  the	  healthcare	  systems,	  patient	  populations,	  
and	  treatment	  traditions	  in	  the	  Nordic	  countries	  are	  rather	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homogenous,	  there	  is	  no	  consensus	  regarding	  indication	  for	  
neither	  primary	  THA	  nor	  revision	  procedures.	  	  
	  
The	  Danish	  National	  Patient	  Registry	  (study	  I	  and	  III)	  
The	  DNRP	  was	  established	  in	  1977	  and	  contains	  data	  linked	  to	  the	  
unique	  personal	  identification	  number	  on	  all	  admissions	  and	  
discharges	  from	  somatic	  hospitals	  in	  Denmark,	  including	  dates	  of	  
admissions	  and	  discharges,	  surgical	  procedures	  performed,	  and	  up	  
to	  twenty	  diagnoses	  for	  every	  discharge.	  From	  1977	  to	  1993,	  
diagnoses	  were	  classified	  according	  to	  the	  Danish	  version	  of	  the	  
International	  Classification	  of	  Diseases,	  eighth	  edition,	  and	  since	  
1994	  according	  to	  the	  tenth	  edition.	  From	  1995	  and	  onwards,	  data	  
on	  psychiatric	  hospitalisation	  and	  all	  outpatients	  and	  emergency	  
visits	  have	  been	  included	  into	  the	  registry.	  The	  physician	  who	  
discharges	  the	  patient	  assigns	  all	  discharge	  diagnoses.125	  Data	  from	  
the	  DNRP	  was	  used	  to	  determine	  the	  Charlson	  comorbidity	  index	  
(CCI)	  score.126	  Although	  the	  positive	  predictive	  value	  (PPV)	  for	  
diagnosis	  and	  treatment	  vary	  substantially	  in	  the	  DNPR125,	  the	  
overall	  PPV	  for	  the	  19	  Charlson	  conditions	  was	  98.0%127.	  
	  
Design	  and	  study	  population	  
Randomised	  clinical	  trials	  (RCTs)	  may	  be	  considered	  the	  gold	  
standard	  when	  studying	  THA	  as	  an	  intervention.	  However,	  RCTs	  
are	  labour-­‐demanding	  and	  relatively	  costly,	  which	  may	  limit	  their	  
use	  when	  examining	  rare	  outcomes.	  In	  such	  situations,	  
observational	  cohort	  studies	  based	  on	  national	  registries	  are	  
suitable	  as	  large	  study	  populations	  can	  be	  obtained.	  
	   Study	  I	  and	  II	  were	  designed	  as	  population-­‐based	  cohort	  
studies.	  As	  registration	  of	  the	  femoral	  head	  and	  acetabular	  liner	  
material	  in	  the	  DHR	  started	  in	  2002,	  patients	  operated	  before	  2002	  
were	  not	  included	  in	  the	  studies.	  In	  study	  I,	  a	  data	  extract	  from	  
2010	  including	  raw	  data	  on	  all	  primary	  THAs	  operated	  from	  2002	  
to	  2009	  (n=58,731)	  revealed	  that	  55,212	  (94%)	  had	  registered	  the	  
material	  of	  the	  femoral	  head,	  whereas	  46,386	  (79%)	  had	  
registered	  the	  material	  of	  the	  acetabular	  liner.	  When	  combining	  
the	  femoral	  head	  and	  liner	  material	  for	  determination	  of	  the	  	  
	  
Table	  1.	  A	  number	  of	  MoM	  and	  MoP	  THAs	  were	  controls	  for	  more	  
than	  one	  CoC	  THA,	  e.g.	  202	  MoM	  and	  180	  MoP	  THAs	  were	  each	  
controls	  for	  2	  CoC	  THAs	  (study	  III)	  






1	   857	   1,606	  
2	   202	   180	  
3	   81	   26	  
4	   44	   8	  
5	   28	   1	  
6	   25	   0	  
7	   17	   0	  
8	   11	   0	  
9	   9	   0	  
10	   5	   0	  
11	   1	   0	  
	  
Table	  2.	  Number	  of	  patients	  with	  unilateral	  and	  bilateral	  THA	  
(study	  III)	  






Unilateral	  THA	   1,803	   834	   1,584	  
Also	  contralateral	  THA	   222	   23	   22	  
couple	  of	  bearings,	  it	  was	  found	  that	  14,537	  (25%)	  primary	  THAs	  
had	  missing	  data	  on	  bearings.	  This	  problem	  was	  in	  part	  redressed	  
both	  retrospectively	  and	  prospectively	  by	  changes	  in	  the	  software	  
(Klinisk	  Målesystem)	  used	  to	  report	  data	  on	  THA	  procedures	  to	  the	  
DHR.	  In	  a	  new	  data	  extract	  from	  2012	  including	  primary	  THAs	  from	  
the	  same	  time	  period,	  the	  proportion	  of	  THAs	  registered	  with	  
missing	  data	  on	  couple	  of	  bearings	  was	  reduced	  to	  5%	  (2,942	  of	  
59,431).	  The	  latter	  data	  extract	  from	  the	  DHR	  was	  used	  in	  study	  I.	  
The	  eligible	  number	  of	  cementless	  THA	  in	  patients	  diagnosed	  with	  
primary	  OA	  of	  the	  hip,	  inflammatory	  arthritis,	  femoral	  head	  
osteonecrosis,	  and	  childhood	  hip	  disorder	  was	  25,656.	  Of	  these,	  
11,096	  THAs	  with	  either	  CoC	  (n=1,773)	  or	  MoP	  (n=9,323)	  bearings	  
were	  included.	  In	  study	  II,	  the	  eligible	  number	  of	  cementless	  THA	  
was	  85,371	  and	  of	  these,	  32,678	  THAs	  having	  MoM	  (n=11,567)	  and	  
MoP	  (n=21,111)	  bearings	  were	  included.	  
	   Study	  III	  was	  initially	  designed	  as	  a	  cross-­‐sectional	  case-­‐
comparison	  cohort	  study.	  One	  case	  having	  CoC	  THA	  was	  randomly	  
matched	  on	  sex,	  year	  of	  birth,	  and	  year	  of	  surgery	  to	  one	  patient	  
with	  MoM	  and	  one	  patient	  with	  MoP	  THA.	  Matching	  was	  
performed	  in	  order	  to	  eliminate	  the	  confounding	  effect	  of	  sex,	  age,	  
and	  follow-­‐up.	  After	  matching,	  2,025	  CoC,	  1,280	  MoM,	  and	  1,821	  
MoP	  THAs	  were	  identified	  and	  clearly,	  it	  was	  not	  possible	  to	  find	  a	  
unique	  match	  to	  each	  case.	  Furthermore,	  a	  large	  number	  of	  
patients	  with	  MoM	  and	  MoP	  THA	  were	  matched	  to	  more	  than	  one	  
CoC	  THA	  (Table	  1),	  and	  in	  some	  cases	  and	  matched	  patients	  
operated	  bilaterally	  both	  THAs	  were	  included	  (Table	  2).	  Even	  
though	  patients	  with	  MoM	  and	  MoP	  THA	  were	  matched	  to	  more	  
than	  one	  CoC	  THA,	  these	  patients	  should	  only	  receive	  one	  
questionnaire.	  Moreover,	  only	  the	  first	  THA	  was	  included	  in	  case	  
of	  bilateral	  THA.	  Thus,	  1,803	  patients	  with	  CoC	  THA,	  834	  patients	  
with	  MoM	  THA,	  and	  1,584	  patients	  with	  MoP	  THA	  were	  included.	  
Another	  limitation	  related	  to	  the	  matching	  was	  non-­‐responders,	  
i.e.	  patients	  who	  did	  not	  return	  a	  fulfilled	  questionnaire.	  If	  the	  
matched	  case-­‐comparison	  cohort	  design	  should	  be	  maintained,	  
the	  corresponding	  case	  and	  matched	  patients	  should	  be	  omitted,	  
when	  one	  of	  the	  three	  was	  a	  non-­‐responder.	  This	  would	  have	  
resulted	  in	  a	  significant	  reduction	  of	  the	  study	  population,	  which	  
then	  only	  would	  have	  consisted	  of	  621	  patients.	  Therefore,	  the	  
case-­‐comparison	  cohort	  design	  was	  abandoned	  in	  favour	  of	  a	  
cohort	  study	  design	  and	  instead,	  adjustments	  for	  sex,	  age,	  and	  




In	  study	  I-­‐III,	  patients	  having	  implanted	  hip	  resurfacing	  
arthroplasties	  or	  dual	  mobility	  acetabular	  systems	  (Table	  3)	  were	  
excluded	  due	  to	  the	  different	  prosthetic	  concept	  and	  design	  with	  
specific	  risks	  and	  complications,	  e.g.	  femoral	  neck	  fracture,	  for	  hip	  
resurfacing	  arthroplasties,	  and	  specific	  patient	  selection,	  e.g.	  
mentally	  disabled	  patients,	  for	  dual	  mobility	  acetabular	  systems.	  
Thus,	  only	  patients	  having	  stemmed	  THA	  with	  a	  standard	  cup	  were	  
included.	  Further,	  patients	  diagnosed	  with	  acute	  or	  sequelae	  from	  
traumatic	  hip	  disorder	  were	  excluded	  from	  the	  study	  populations,	  
because	  these	  patients	  have	  a	  specific	  risk	  profile	  including	  
comorbidity	  influencing	  the	  outcome	  of	  THA.	  Also	  patients	  
diagnosed	  with	  “other”	  diagnoses	  (than	  OA,	  femoral	  head	  
osteonecrosis,	  inflammatory	  arthritis,	  and	  sequelae	  from	  
childhood	  hip	  disorder),	  which	  includes	  patients	  having	  a	  specific	  
risk	  profile	  due	  to,	  for	  instance,	  primary	  tumour	  or	  metastases,	  
were	  excluded.	  As	  fixation	  is	  a	  well-­‐known	  confounder	  and	  the	  
vast	  majority	  of	  CoC	  (97.1%)	  and	  MoM	  THAs	  (86.5%)	  had	  
cementless	  fixation,	  only	  cementless	  THAs	  were	  included	  in	  study	  I	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Table	  3.	  Designs	  and	  manufacturers	  of	  dual	  mobility	  acetabular	  
systems	  checked	  for	  and	  excluded	  from	  the	  study	  populations	  
Brand	   Manufacturer	  
Acorn	  Double	  Mobility	  Cup	   Permedica	  
Avantage	   Biomet	  
Collegia	   Cremascoli-­‐Wright	  
Dual	  Mobility	  Cup	   Tornier	  
EOL	   Norton-­‐Ceramconcept	  
Evora	   Science	  et	  Médecine	  
Gyros	   DePuy	  
Modular	  Dual	  Mobility	   Stryker	  
Novae-­‐1	  	   Serf	  
Novae-­‐E	   Serf	  
Novae	  Sunfit	   Serf	  
Polarcup	   Smith	  &	  Nephew	  
Restoration	  Anatomic	  Dual	  Mobility	   Stryker	  
Saturne	   Wright	  
Saturne	  Reconstruction	   Wright	  
seleXys	  DS	   Mathys	  
seleXys	  DS	  Revision	   Mathys	  
Stafit	   Zimmer	  
Tregor	   Aston	  
Versafitcup	  Double	  Mobility	   Medacta	  
	  
and	  II.	  In	  study	  III,	  all	  fixation	  methods	  were	  included	  and	  adjusted	  
for	  in	  the	  analyses.	  
	  
Questionnaires	  (study	  III)	  
The	  set	  of	  questionnaires	  was	  supplemented	  by	  questions	  
concerning	  the	  current	  height	  and	  weight.	  Patients	  were	  also	  
asked	  to	  indicate	  by	  “yes”	  or	  “no”,	  if	  they	  had	  undergone	  any	  
reoperation	  in	  the	  specified	  hip	  with	  removal	  or	  exchange	  of	  the	  
whole	  or	  any	  parts	  of	  the	  implant	  since	  primary	  surgery.	  
	  
HOOS	  
The	  disease-­‐specific	  hip	  disability	  and	  osteoarthritis	  outcome	  score	  
(HOOS)128	  was	  constructed	  by	  adding	  dimensions	  concerning	  sport	  
and	  recreation	  function	  and	  hip-­‐related	  QoL	  to	  the	  Western	  
Ontario	  and	  McMaster	  Universities	  Osteoarthritis	  Index	  
(WOMAC)129.	  In	  study	  III,	  HOOS	  was	  chosen	  as	  it	  is	  well	  validated	  
and	  widely	  used,	  but	  other	  disease-­‐specific	  questionnaires,	  e.g.	  the	  
Oxford	  Hip	  Score130,	  which	  is	  translated	  into	  Danish	  and	  validated	  
in	  a	  Danish	  registry	  setting131,132,	  could	  also	  have	  been	  used.	  In	  
contrast,	  the	  HHS	  is	  not	  self-­‐administered	  and	  therefore	  not	  
suitable	  for	  a	  questionnaire	  survey.	  
	   The	  HOOS	  is	  constituted	  of	  five	  subscales	  (dimensions):	  pain	  
(HOOS	  Pain),	  other	  symptoms	  (HOOS	  Symptoms),	  activities	  of	  daily	  
living	  (HOOS	  ADL),	  sport	  and	  recreation	  function	  (HOOS	  Sport),	  
and	  hip	  related	  QoL	  (HOOS	  QoL).	  The	  validation	  of	  the	  instrument	  
includes	  assessment	  of	  content	  and	  construct	  validity,	  
responsiveness,	  minimal	  clinically	  important	  improvement	  (MCII),	  
and	  patient-­‐acceptable	  symptom	  state	  (PASS).128,133,134	  HOOS	  is	  
recommended	  for	  evaluation	  of	  patients	  diagnosed	  with	  OA	  of	  the	  
hip	  treated	  non-­‐surgically	  or	  with	  THA.135	  For	  each	  subscale,	  a	  
score	  from	  0	  to	  100	  is	  computed:	  A	  score	  of	  100	  indicates	  no	  
problems	  and	  0	  indicates	  extreme	  problems.	  If	  at	  least	  50%	  of	  
items	  in	  the	  subscale	  have	  been	  answered,	  the	  subscale	  score	  can	  
be	  calculated	  (HOOS	  scoring	  instructions	  available	  at	  
http://www.koos.nu/index.html).	  Translation	  and	  cross-­‐cultural	  
adaptation	  of	  the	  original	  Swedish	  version	  of	  HOOS	  into	  Danish	  has	  
been	  done	  using	  existing	  guidelines136	  although	  no	  testing	  of	  
validity,	  reliability,	  and	  responsiveness	  in	  a	  Danish	  population	  has	  
been	  performed.	  As	  the	  Danish	  and	  Swedish	  cultures	  are	  very	  
similar,	  it	  is	  reasonable	  to	  assume,	  that	  there	  is	  no	  difference	  on	  
validity,	  reliability,	  and	  responsiveness	  in	  the	  two	  cultures.	  
	  
EQ-­‐5D	  
The	  EuroQol	  EQ-­‐5D-­‐3L	  is	  a	  generic,	  reliable	  and	  validated	  
instrument	  used	  for	  measure	  of	  QoL	  and	  is	  applicable	  to	  a	  wide	  
range	  of	  health	  conditions	  and	  treatments	  including	  hip	  OA,	  THA,	  
and	  revision	  hip	  arthroplasty.137-­‐140	  The	  EQ-­‐5D-­‐3L	  was	  chosen	  as	  
the	  generic	  questionnaire,	  as	  it	  is	  used	  in	  the	  Swedish	  Hip	  
Arthroplasty	  Register	  (SHAR)	  and	  the	  National	  Joint	  Registry	  for	  
England,	  Wales,	  Northern	  Ireland	  and	  Isle	  of	  Man	  (NJR).10,14	  
Furthermore,	  the	  ED-­‐5D-­‐3L	  was	  used	  in	  a	  Danish	  registry	  setting132,	  
and	  it	  takes	  only	  a	  few	  minutes	  to	  fill	  in.	  Other	  relevant	  generic	  
questionnaires	  that	  could	  have	  been	  used	  is	  the	  Short-­‐Form	  12141.	  
	   The	  EQ-­‐5D	  index	  describes	  the	  health-­‐related	  QoL	  from	  a	  
social	  perspective	  and	  the	  EQ	  visual	  analogue	  scale	  (VAS)	  from	  the	  
patient’s	  perspective.	  The	  EQ-­‐5D	  index	  is	  determined	  from	  five	  
dimensions:	  mobility,	  self-­‐care,	  usual	  activities,	  pain/discomfort,	  
and	  anxiety/depression,	  each	  with	  three	  levels	  (no	  problems,	  
some/moderate	  problems,	  and	  extreme	  problems/unable	  to)	  
resulting	  in	  35=243	  possible	  health	  states.	  The	  EQ-­‐5D	  is	  translated	  
into	  Danish,	  and	  based	  on	  the	  time	  trade-­‐off	  method142,	  a	  value	  
set	  ranging	  from	  -­‐0.624	  to	  1,	  where	  1	  describes	  full	  health,	  0	  
represents	  being	  dead,	  and	  a	  negative	  value	  represents	  a	  health	  
state	  worse	  than	  being	  dead,	  constitutes	  the	  Danish	  culture-­‐
adjusted	  EQ-­‐5D	  index143.	  The	  EQ	  VAS	  is	  determined	  when	  the	  
patients	  rate	  their	  current	  state	  of	  health	  on	  a	  thermometer	  scale	  
ranging	  from	  0	  (“worst	  imaginable”)	  to	  100	  (“best	  imaginable”).	  A	  
newer	  version	  of	  the	  EQ-­‐5D	  (EQ-­‐5D-­‐5L)	  with	  five	  levels	  (no	  
problems,	  slight	  problems,	  moderate	  problems,	  severe	  problems,	  
and	  extreme	  problems/unable	  to)	  for	  each	  of	  the	  five	  dimensions	  
has	  been	  developed	  in	  order	  to	  improve	  the	  sensitivity	  and	  to	  
reduce	  floor	  and	  ceiling	  effects.144,145	  The	  EQ-­‐5D-­‐5L	  was	  compared	  
to	  the	  EQ-­‐5D-­‐3L	  in	  patients	  with	  hip	  and	  knee	  OA	  referred	  to	  total	  
joint	  replacement	  and	  provided	  stronger	  evidence	  of	  validity	  
specifically	  for	  the	  dimensions	  mobility,	  usual	  activities,	  and	  
pain/discomfort	  that	  are	  particularly	  relevant	  for	  OA	  patients.146	  
	  
UCLA	  activity	  score	  
University	  of	  California,	  Los	  Angeles	  (UCLA)	  activity	  score	  was	  first	  
described	  in	  1984,	  is	  disease-­‐specific,	  and	  has	  10	  descriptive	  
activity	  levels	  ranging	  from	  wholly	  inactive	  and	  dependent	  on	  
others	  (level	  1),	  to	  moderate	  activities	  such	  as	  unlimited	  
housework	  and	  shopping	  (level	  6),	  to	  regular	  participation	  in	  
impact	  sports	  such	  as	  jogging	  or	  tennis	  (level	  10).	  Regardless	  of	  
frequency	  or	  intensity	  of	  participation,	  the	  UCLA	  activity	  score	  is	  
based	  on	  the	  highest-­‐rated	  activity.147	  The	  UCLA	  activity	  score,	  
which	  includes	  different	  types	  of	  sporting	  activities,	  was	  included	  
in	  the	  questionnaire	  to	  supplement	  the	  Sport	  subscale	  in	  the	  
HOOS.	  The	  activity	  score	  is	  found	  to	  correlate	  well	  to	  pedometer	  
data	  in	  a	  population	  but	  for	  individual	  patients	  with	  the	  same	  
UCLA	  activity	  score,	  the	  difference	  in	  the	  average	  steps	  per	  day	  
could	  vary	  by	  up	  to	  a	  factor	  of	  15.148	  The	  UCLA	  activity	  score	  was	  
compared	  to	  the	  International	  Physical	  Activity	  Questionnaire	  as	  
gold	  standard	  and	  was	  found	  to	  be	  the	  most	  appropriate	  scale	  for	  
assessment	  of	  physical	  activity	  levels	  in	  patients	  undergoing	  total	  
joint	  replacement,	  as	  it	  had	  high	  reliability	  and	  completion	  rate	  
and	  showed	  no	  floor	  effects.149	  A	  validated	  Danish	  version	  of	  the	  
UCLA	  activity	  score,	  although	  not	  published	  yet,	  was	  used.	  
	  
Questionnaire	  about	  noises	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Owen	  et	  al.	  defined	  noises	  as	  any	  audible	  sound	  that	  the	  patient	  
perceived	  as	  originating	  from	  the	  THA.150	  Other	  authors	  have	  
defined	  a	  squeaking	  as	  a	  squeaking,	  clicking,	  or	  grating	  sound	  with	  
origin	  from	  the	  THA	  during	  movement151,	  thus	  classifying	  different	  
qualities	  of	  noises	  as	  squeaking,	  whereas	  noises	  from	  THA	  also	  
have	  been	  described	  as	  “pops”,	  “snaps”,	  and	  “grinds”	  by	  other	  
authors7.	  In	  2010,	  Swanson	  et	  al.	  proposed	  a	  scale	  for	  grading	  the	  
frequency	  and	  the	  intensity	  of	  the	  noise,	  and	  the	  authors	  defined	  
“problem	  squeaking”	  as	  any	  squeak	  always	  audible	  to	  others	  and	  
occurring	  at	  least	  once	  per	  week.152	  Furthermore,	  the	  Melbourne	  
Orthopaedic	  Noise	  Assessment,	  including	  questions	  about	  noise	  
frequency,	  noise	  type,	  and	  audibility	  of	  the	  noise	  to	  others,	  was	  
published	  in	  2013.112	  For	  aim	  III,	  a	  questionnaire	  to	  collect	  
information	  on	  noises	  from	  THA	  was	  created	  based	  on	  the	  
literature.7,152	  All	  patients	  were	  asked	  if	  they	  had	  experienced	  
noises	  from	  the	  THA.	  If	  confirmed,	  they	  were	  asked	  to	  characterise	  
the	  noises	  as	  squeaking,	  creaking,	  grating,	  clicking,	  or	  other.	  
Furthermore,	  patients	  were	  asked	  to	  answer	  questions	  about	  
onset	  (number	  of	  months	  after	  surgery	  at	  which	  the	  noises	  
started),	  frequency	  (at	  least	  once	  a	  day,	  at	  least	  once	  a	  week,	  more	  
seldom	  than	  once	  a	  week),	  audibility	  (only	  audible	  to	  the	  patient,	  
from	  time	  to	  time	  audible	  to	  others,	  always	  audible	  to	  others),	  
activities	  triggering	  the	  noises	  (rising	  from	  a	  chair,	  sitting	  down,	  
bending,	  walking,	  walking	  up	  or	  down	  the	  steps,	  climbing	  a	  high	  
step,	  or	  other	  activity),	  and	  what	  degree	  noises	  led	  to	  reduced	  
physical	  function	  and	  hindered	  the	  patient	  being	  together	  with	  
other	  people	  (“no”,	  “slight”,	  “moderate”,	  “severe”,	  or	  “extreme”).	  
Among	  all	  authors,	  consensus	  was	  obtained	  regarding	  phrasing	  of	  
the	  questions.	  Subsequently,	  the	  questions	  about	  noises	  were	  
slightly	  adjusted	  through	  a	  test	  phase	  based	  on	  18	  patients	  
randomly	  selected	  among	  patients	  admitted	  to	  Department	  of	  
Orthopaedic	  Surgery,	  Vejle	  Hospital,	  Denmark	  for	  primary	  THA	  
surgery.	  Furthermore,	  three	  patients	  who	  had	  undergone	  revision	  
at	  the	  same	  department	  of	  their	  CoC	  THA	  due	  to	  noises	  tested	  the	  
questions	  and	  found	  these	  relevant	  and	  meaningful.	  Although	  the	  
questions	  about	  noises	  do	  not	  result	  in	  an	  overall	  score,	  a	  major	  
drawback	  is	  that	  the	  questions	  are	  not	  properly	  evaluated	  in	  
relation	  to	  content	  and	  construct	  validity,	  and	  no	  test-­‐retest	  in	  a	  
smaller	  proportion	  of	  the	  patients	  have	  been	  performed.	  Further,	  
no	  objective	  assessment	  has	  been	  made	  to	  validate	  the	  self-­‐
reported	  noises.	  However,	  in	  the	  literature	  no	  thorough	  validation	  
of	  questions	  on	  noises	  from	  THA	  has	  been	  made,	  and	  the	  
definition	  of	  “problem	  squeaking”	  was	  made	  by	  Swanson	  et	  al.	  
without	  knowing	  if	  this	  definition	  was	  meaningful	  for	  the	  patients	  
with	  squeaking	  THA.152	  
	  
Choice	  of	  PROM	  
Since	  2002,	  PROMs	  have	  been	  included	  stepwise	  in	  the	  SHAR	  in	  
order	  to	  increase	  the	  sensitivity	  of	  the	  registry.	  Patients	  
undergoing	  primary	  THA	  are	  asked	  to	  complete	  a	  self-­‐
administered	  questionnaire,	  including	  Charnley’s	  functional	  
categories,	  a	  VAS	  for	  pain	  and	  satisfaction,	  and	  the	  EQ-­‐5D.	  This	  is	  
done	  preoperatively	  (except	  for	  satisfaction)	  and	  at	  one,	  six,	  and	  
ten	  years	  postoperatively	  unless	  the	  patient	  has	  undergone	  
revision	  surgery.10	  A	  study	  comparing	  collection	  of	  PROM	  data	  
with	  either	  pen-­‐and-­‐paper	  or	  internet	  questionnaires	  found	  that	  
the	  response	  rates	  for	  pen-­‐and-­‐paper	  and	  internet	  questionnaires	  
were	  49%	  and	  92%,	  respectively.153	  This	  is	  in	  contrast	  to	  a	  small	  
series	  study	  that	  reported	  very	  high	  correlation	  of	  scores	  from	  
HHS,	  WOMAC,	  Short	  Form-­‐36,	  EQ-­‐5D,	  and	  UCLA	  activity	  score	  
obtained	  with	  the	  paper,	  touch	  screen,	  and	  web-­‐based	  modes.154	  
However,	  the	  use	  of	  pen-­‐and-­‐paper	  questionnaire	  is	  costly	  and	  
laborious	  due	  to	  postage	  and	  double	  manual	  data	  entry.	  With	  the	  
use	  of	  HOOS	  and	  EQ-­‐5D-­‐3L	  questionnaires,	  Paulsen	  et	  al.	  
performed	  a	  comparison	  between	  automated	  forms	  processing	  
and	  double	  manual	  data	  entry	  for	  highly	  structured	  forms	  
containing	  only	  check	  boxes,	  numerical	  codes	  and	  no	  dates,	  and	  no	  
differences	  in	  the	  proportion	  of	  errors	  were	  found.155	  Moreover,	  
HOOS	  and	  EQ-­‐5D-­‐3L	  were	  found	  appropriate	  for	  administration	  in	  
a	  hip	  arthroplasty	  registry.132	  To	  compare	  symptoms,	  function,	  
activity,	  and	  QoL	  before	  and	  after	  primary	  THA,	  both	  a	  generic	  and	  
a	  disease-­‐specific	  questionnaire	  can	  be	  administered	  via	  the	  
Internet	  with	  supplement	  of	  pen-­‐and-­‐paper	  questionnaire	  
prepared	  for	  automated	  forms	  processing.	  
	   Several	  factors	  may	  be	  taken	  into	  account	  when	  interpreting	  
the	  PROMs.	  Patients’	  preoperative	  expectations	  to	  THA	  may	  vary	  
considerably,	  and	  Judge	  et	  al.	  reported	  that	  greater	  numbers	  of	  
preoperative	  expectations	  were	  associated	  with	  younger	  age,	  
women,	  increasing	  body	  mass	  index	  (BMI),	  and	  more	  education.	  
Patients	  were	  more	  likely	  to	  improve	  after	  surgery	  the	  more	  
preoperative	  expectations	  they	  had.156	  However,	  other	  authors	  
report,	  that	  there	  was	  no	  association	  between	  the	  level	  of	  
preoperative	  expectations	  and	  fulfilment	  of	  expectations	  or	  
outcome.	  Furthermore,	  there	  was	  no	  relation	  between	  depression	  
and	  expectations.157	  Otherwise,	  patients	  with	  anxiety	  or	  
depression	  preoperatively	  had	  lower	  PROM	  scores	  after	  THA	  than	  
patients	  without	  these	  mental	  disorders.158	  In	  a	  study	  from	  the	  
SHAR,	  changes	  in	  EQ-­‐5D	  index,	  EQ	  VAS,	  and	  pain	  VAS	  increased	  
with	  higher	  educational	  level159,	  and	  other	  authors	  reported	  higher	  
likelihood	  of	  less	  than	  excellent	  or	  good	  HHS	  and	  thigh	  pain	  ≥3	  on	  
a	  VAS	  for	  patients	  with	  less	  than	  a	  high	  school	  education.160	  In	  
another	  study,	  Short	  From-­‐36	  was	  used	  to	  compare	  QoL,	  and	  
completed	  level	  of	  schooling	  had	  no	  effect	  on	  the	  improvement	  in	  
QoL	  after	  THA161,	  which	  indicates	  that	  differences	  may	  appear	  due	  
to	  different	  PROMs,	  study	  designs,	  follow-­‐up,	  and	  cultures.	  None	  
of	  these	  factors	  were	  treated	  separately	  in	  study	  III.	  
	  	  
Statistics	  
In	  all	  studies,	  the	  exposure	  was	  THA	  with	  different	  types	  of	  
bearings:	  CoC	  and	  MoP	  in	  study	  I;	  MoM	  and	  MoP	  in	  study	  II;	  and	  
CoC,	  MoM,	  and	  MoP	  in	  study	  III.	  In	  study	  I	  and	  II,	  the	  primary	  
outcome	  was	  time	  to	  revision	  for	  any	  cause,	  whereas	  time	  to	  
revision	  for	  aseptic	  loosening,	  dislocation,	  and	  other	  causes	  were	  
secondary	  outcomes.	  In	  study	  III,	  the	  outcome	  was	  generic	  and	  
disease-­‐specific	  PROMs.	  
	   Traditionally,	  time-­‐to-­‐event	  or	  survival	  analysis	  has	  been	  
performed	  with	  the	  Cox	  regression,	  but	  competing	  risk	  cannot	  be	  
addressed	  properly	  with	  this	  method162.	  The	  Kaplan-­‐Meier	  
estimator	  used	  in	  Cox	  regression	  overestimates	  the	  risk	  of	  revision	  
when	  the	  risk	  of	  death	  is	  high163,	  and	  THA	  is	  most	  common	  in	  older	  
patients	  having	  higher	  risk	  of	  death	  compared	  to	  younger	  patients.	  
In	  study	  I	  and	  II,	  we	  therefore	  chose	  to	  perform	  the	  survival	  
analysis	  with	  regression	  with	  the	  pseudo-­‐value	  approach	  taking	  
the	  competing	  risk	  of	  death	  into	  account.	  Pseudo-­‐values	  are	  
calculated	  at	  prespecified	  time	  points.	  The	  pseudo-­‐observation	  is	  a	  
transformation	  of	  the	  time-­‐to-­‐event	  data	  in	  which	  each	  time-­‐to-­‐
event	  observation	  is	  represented	  by	  the	  amount	  of	  information	  it	  
contains	  when	  the	  observation	  is	  deleted	  from	  the	  dataset.	  
Subsequently,	  a	  model	  for	  relative	  risk	  (RR)	  for	  the	  uncensored	  
data	  is	  applied	  via	  a	  generalised	  estimating	  equation	  obtained	  in	  a	  
generalised	  linear	  model	  for	  the	  pseudo-­‐values	  with	  normal	  
distribution	  and	  robust	  variance	  estimation.164,165	  The	  pseudo-­‐
value	  method	  relies	  on,	  as	  any	  time-­‐to-­‐event	  analysis,	  the	  
censoring	  being	  independent.	  In	  the	  current	  context	  independent	  
censoring	  is	  satisfied	  since	  the	  risk	  of	  revision	  was	  assumed	  to	  be	  
constant	  over	  calendar	  time.	  The	  measure	  of	  association	  of	  Cox	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regression	  is	  the	  hazard	  ratio	  (HR),	  which	  may	  be	  a	  little	  difficult	  to	  
interpret	  and	  may	  often	  be	  interpreted	  as	  a	  measure	  of	  the	  RR.	  
One	  assumption	  when	  performing	  the	  Cox	  regression	  is	  
proportional	  hazards	  meaning	  that	  the	  HR	  is	  constant	  over	  time,	  
and	  this	  assumption	  was	  not	  fulfilled	  in	  study	  I	  and	  II.	  When	  using	  
regression	  with	  the	  pseudo-­‐value	  approach,	  there	  is	  no	  
assumption	  of	  proportional	  hazards	  to	  be	  satisfied.	  Another	  
advantage	  is,	  that	  the	  measure	  of	  association	  of	  regression	  with	  
the	  pseudo-­‐value	  approach	  is	  a	  real	  RR,	  which	  may	  ease	  the	  
interpretation	  of	  the	  results.	  However,	  a	  drawback	  with	  this	  
method,	  and	  contrary	  to	  the	  Cox	  regression,	  is	  that	  it	  is	  not	  
possible	  to	  have	  survival	  curves	  adjusted	  for	  confounders.	  	  
	   In	  study	  III,	  multivariate	  linear	  regression	  has	  been	  performed	  
to	  determine	  adjusted	  mean	  differences	  of	  PROM	  scores	  between	  
the	  types	  of	  bearings.	  For	  the	  HOOS	  subscales,	  EQ-­‐5D	  index,	  and	  
EQ	  VAS	  the	  resulting	  scores	  are	  continuous.	  For	  the	  UCLA	  activity	  
score,	  the	  resulting	  score	  is	  between	  one	  and	  ten,	  but	  each	  
individual	  score	  corresponds	  to	  one	  activity	  statement,	  and	  the	  
difference	  in	  activity	  level	  between	  score	  two	  and	  three	  is	  not	  the	  
same	  as,	  for	  instance,	  between	  score	  seven	  and	  eight.	  Therefore,	  
one	  could	  argue	  that	  the	  appropriate	  analysis	  would	  have	  been	  
one	  for	  ordered	  categorical	  outcome,	  e.g.	  ordinal	  logistic	  
regression.	  One	  of	  the	  drawbacks	  with	  the	  use	  of	  such	  a	  model	  is,	  
that	  the	  outcome	  is	  an	  odds	  ratio,	  which	  is	  more	  difficult	  to	  
interpret	  than	  mean	  and	  mean	  difference	  from	  linear	  regression.	  
Furthermore,	  in	  studies	  using	  the	  UCLA	  activity	  score	  the	  outcome	  
has	  been	  described	  as	  means.149,166	  Hence,	  no	  comparison	  of	  the	  
results	  in	  study	  III	  with	  other	  studies	  would	  have	  been	  possible,	  if	  
ordinal	  logistic	  regression	  had	  been	  used.	  Therefore,	  linear	  
regression	  was	  performed	  to	  analyse	  the	  UCLA	  activity	  score	  in	  
study	  III	  knowing	  full	  well	  that	  the	  results	  may	  be	  interpreted	  with	  
caution	  as	  the	  UCLA	  activity	  score	  had	  been	  treated	  as	  a	  
continuous	  variable.	  
	  
Bias	  and	  confounding	  
Several	  factors	  may	  influence	  the	  validity	  of	  our	  results.	  The	  
association	  observed	  could	  have	  several	  explanations	  that	  have	  to	  
be	  considered	  before	  inferring	  a	  causal	  association.	  These	  factors	  
include	  selection	  problems	  potentially	  leading	  to	  selection	  bias,	  
information	  problems	  potentially	  leading	  to	  information	  bias,	  
chance,	  and	  confounding	  (Figure	  3).	  	  
	  
Selection	  bias	  
In	  general,	  selection	  problems	  in	  a	  cohort	  study	  can	  occur	  due	  to	  
lost	  to	  follow-­‐up.	  However,	  in	  study	  I	  and	  II	  we	  have	  complete	  
follow-­‐up	  of	  all	  patients	  included	  in	  the	  study	  population.	  Thus,	  
selection	  bias	  is	  not	  likely.	  In	  contrast,	  selection	  bias	  may	  influence	  
the	  results	  in	  study	  III,	  as	  patients	  who	  did	  not	  answer	  the	  
questionnaire	  (non-­‐responders)	  were	  lost	  to	  follow-­‐up.	  Non-­‐
responders	  had	  a	  greater	  proportion	  of	  patients	  younger	  than	  50	  
years	  and	  smaller	  proportion	  of	  patients	  aged	  70	  years	  or	  older,	  
which	  may	  result	  in	  lower	  activity	  scores	  in	  study	  III,	  as	  younger	  
patients	  are	  more	  active	  than	  older.	  Among	  non-­‐responders,	  a	  
smaller	  proportion	  was	  diagnosed	  with	  OA	  and	  a	  greater	  
proportion	  with	  other	  diagnoses,	  which	  corresponds	  well	  with	  
differences	  in	  the	  age	  groups.	  Furthermore,	  there	  was	  a	  smaller	  
proportion	  without	  comorbidity	  and	  a	  greater	  proportion	  with	  
high	  comorbidity,	  which	  may	  give	  higher	  PROM	  scores	  in	  the	  
study.	  Among	  non-­‐responders	  there	  was	  a	  smaller	  proportion	  with	  
CoC	  bearings,	  and	  a	  greater	  proportion	  of	  patients	  with	  MoP	  
bearings	  than	  responders,	  which	  may	  be	  explained	  by	  the	  greater	  
proportion	  of	  patients	  with	  high	  comorbidity	  that	  are	  more	  likely	  
to	  be	  treated	  with	  MoP	  THA.	  
	   In	  study	  I,	  another	  selection	  problem	  can	  occur	  because	  the	  
use	  of	  CoC	  bearings	  may	  be	  reserved	  for	  young	  and	  active	  patients	  
as	  recommended	  by	  some	  authors167,	  or	  some	  departments	  may	  
have	  CoC	  as	  their	  “standard”	  bearings,	  whereas	  other	  departments	  
may	  reserve	  these	  bearings	  for	  only	  very	  rare	  cases,	  e.g.	  very	  
young	  patients	  suffering	  from	  childhood	  hip	  disorders168.	  In	  study	  
II,	  there	  is	  a	  greater	  proportion	  of	  males,	  a	  greater	  proportion	  
diagnosed	  with	  OA,	  and	  a	  smaller	  proportion	  diagnosed	  with	  
childhood	  hip	  disorders	  operated	  with	  MoM	  compared	  to	  MoP	  
bearings.	  Furthermore,	  in	  Denmark	  not	  all	  orthopaedic	  
departments	  have	  used	  MoM	  bearing	  in	  THA,	  and	  within	  the	  
Nordic	  countries	  there	  is	  a	  huge	  variation	  in	  the	  use	  of	  MoM	  THA:	  
In	  study	  II,	  72%	  of	  patients	  were	  operated	  in	  Finland,	  23%	  in	  
Denmark,	  and	  5%	  in	  Sweden	  and	  Norway.	  These	  differences	  may	  
reflect	  surgeons’	  preferences,	  the	  “culture”	  for	  using	  
alternative/new	  implants,	  and	  socioeconomic	  circumstances	  and	  
may	  result	  in	  better	  outcome	  for	  patients	  treated	  in	  countries,	  in	  
hospitals,	  and	  by	  surgeons	  with	  greater	  experience	  with	  the	  
specific	  bearings.	  
	  
Information	  bias	  	  
In	  registry-­‐based	  cohort	  studies,	  information	  problems	  can	  occur	  
due	  to	  misclassification	  of	  exposure	  or	  outcome.	  However,	  only	  if	  
misclassification	  of	  exposure	  is	  dependent	  of	  misclassification	  of	  
outcome	  (hence,	  when	  misclassification	  is	  differential),	  the	  results	  
may	  be	  influenced	  by	  information	  bias.	  We	  may	  have	  
misclassification	  of	  both	  exposure	  and	  outcome,	  but	  if	  these	  were	  
independent	  of	  each	  other	  (non-­‐differential	  misclassification),	  the	  
RR	  estimates	  would	  go	  towards	  the	  null	  hypothesis.	  
	   In	  studies	  I-­‐III,	  misclassification	  of	  bearings	  can	  occur,	  if	  data	  
are	  missing	  or	  registered	  incorrectly.	  The	  lack	  of	  validation	  of	  data,	  
e.g.	  bearings,	  implant	  design,	  femoral	  head	  size,	  and	  causes	  of	  
revision,	  in	  the	  DHR	  and	  the	  NARA	  database	  may	  give	  rise	  to	  
concerns	  related	  to	  the	  quality	  of	  these	  data.	  In	  study	  I	  and	  II,	  
misclassification	  is	  obviously	  related	  to	  the	  unambiguous	  
registration	  of	  a	  couple	  of	  bearings.	  However,	  the	  misclassification	  
of	  causes	  of	  revision	  was	  unlikely	  to	  be	  related	  to	  the	  registration	  
of	  the	  type	  of	  bearings	  for	  primary	  THAs	  due	  to	  the	  prospective	  
registration	  of	  data	  in	  DHR	  and	  the	  NARA	  dataset.	  The	  resulting	  
non-­‐differential	  misclassification	  may	  produce	  bias	  towards	  the	  
	  
Figure	  3.	  Bias,	  chance,	  and	  confounding	  should	  be	  excluded	  before	  
concluding	  that	  a	  causal	  association	  is	  likely.	  From	  Fletcher	  RH,	  
Fletcher	  SW,	  Fletcher	  GS.	  Clinical	  Epidemiology:	  The	  Essentials.	  5th	  
edition.	  Lippincott	  Williams	  &	  Wilkins	  2015	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null	  hypothesis.	  Moreover,	  the	  two	  worst-­‐case	  scenarios	  that	  all	  
patients	  registered	  with	  missing	  bearings	  had	  either	  CoC	  or	  MoP	  
(study	  I)	  and	  MoM	  or	  MoP	  (study	  II)	  have	  been	  calculated.	  In	  
neither	  of	  the	  studies,	  the	  RR	  for	  revision	  of	  any	  cause	  was	  
significantly	  changed	  in	  any	  of	  these	  scenarios.	  Although	  the	  
proportion	  of	  missing	  data	  in	  study	  III	  was	  low,	  non-­‐differential	  
misclassification	  may	  be	  present,	  as	  there	  was	  no	  difference	  in	  
missing	  subscale	  scores	  between	  bearing	  groups.	  Misclassification	  
was	  minimised	  by	  using	  well	  validated	  questionnaires	  (HOOS,	  EQ-­‐
5D-­‐3L,	  and	  UCLA	  activity	  score)	  and	  relevant	  questions	  about	  
noises	  from	  the	  THA.	  Five	  to	  nine	  answer	  categories	  on	  a	  scale	  
have	  been	  proposed	  to	  be	  ideal	  in	  most	  circumstances169	  and	  in	  43	  
of	  68	  items,	  five	  steps	  were	  present	  in	  the	  response	  scale.	  
Furthermore,	  no	  evident	  external	  interests	  were	  present.	  The	  
resulting	  high	  response	  rate	  (85%)	  reduces	  the	  misclassification.	  
	   Recall	  bias	  may	  be	  a	  problem	  for	  retrospective	  items.	  Thus	  in	  
study	  III,	  in	  question	  no.	  7	  about	  onset	  of	  noises	  from	  the	  THA,	  50-­‐
52%	  of	  patients	  with	  noises	  from	  the	  THA	  indicated	  that	  the	  onset	  




Chance,	  or	  random	  error,	  is	  inherent	  in	  all	  observations.	  The	  
statistical	  precision	  of	  an	  estimate	  is	  expressed	  as	  a	  confidence	  
interval	  (CI)	  that	  represents	  the	  range	  of	  values	  that	  is	  likely	  to	  
include	  the	  true	  value.	  Statistical	  precision	  increases	  with	  the	  
statistical	  power	  of	  the	  study,	  which	  is	  dependent	  of	  the	  sample	  
size.	  We	  have	  performed	  large	  cohort	  studies	  resulting	  in	  
increased	  precision	  of	  the	  estimates,	  but	  sample	  size	  calculation	  
has	  not	  been	  performed.	  
	  
Confounding	  
Three	  conditions	  must	  be	  present	  for	  confounding	  to	  occur:	  	  
1. The	  confounding	  factor	  must	  be	  associated	  with	  both	  the	  
exposure	  and	  the	  outcome.	  
2. The	  confounding	  factor	  must	  be	  distributed	  unequally	  
among	  the	  groups	  being	  compared.	  
3. A	  confounder	  cannot	  be	  an	  intermediary	  step	  in	  the	  causal	  
pathway	  from	  exposure	  to	  outcome.	  
	   In	  a	  study	  by	  Johnsen	  et	  al.	  from	  the	  DHR,	  males	  had	  a	  20%	  
higher	  RR	  of	  any	  revision	  compared	  to	  females,	  and	  patients	  
younger	  than	  60	  years	  had	  increased	  RR	  of	  revision	  after	  0.5-­‐year	  
follow-­‐up.	  Diagnosis	  was	  found	  to	  be	  a	  time-­‐dependent	  predictor,	  
although	  no	  difference	  in	  RR	  of	  revision	  was	  found	  for	  any	  
diagnosis	  after	  0.5-­‐year	  follow-­‐up,	  whereas	  high	  CCI	  predicted	  
higher	  RR	  of	  revision.18	  For	  sex,	  age,	  diagnosis,	  and	  
	  
Table	  4.	  Confounders	  adjusted	  for	  in	  study	  I-­‐III	  
Confounders	   Study	  I	   Study	  II	   Study	  III	  
Patient-­‐related	   	   	   	  
Sex	   X	   X	   X	  
Age	   X	   X	   X	  
Diagnosis	   X	   X	   X	  
Comorbidity	   X	   	   X	  
BMI	   	   	   X	  
Surgery-­‐related	   	   	   	  
Fixation	   	   	   X	  
Femoral	  head	  size	   X	   	   X	  
Duration	  of	  
surgery	   X	   	   	  
Year	  of	  surgery	   X	   	   X	  
comorbidity,the	  definition	  of	  confounding	  is	  fulfilled,	  and	  
adjustments	  were	  made	  for	  these	  four	  patient-­‐related	  
confounders	  in	  order	  to	  eliminate	  the	  confounding	  effect	  on	  the	  
results	  (Table	  4).	  Adjustment	  for	  comorbidity	  has	  not	  been	  
performed	  in	  study	  II,	  as	  the	  NARA	  database	  do	  not	  contain	  any	  
information	  allowing	  for	  determination	  of	  the	  CCI	  score	  or	  other	  
evaluation	  of	  the	  comorbidity.	  BMI	  and	  THA	  due	  to	  OA	  may	  be	  
associated170,	  and	  BMI	  >35	  kg/m2	  has	  been	  found	  to	  be	  a	  predictor	  
for	  revision	  due	  to	  PJI:	  RR=2.1	  (95%	  CI:	  1.1–4.3)	  for	  BMI	  35–39.9	  
and	  RR=4.2	  (95%	  CI:	  1.8–9.7)	  for	  BMI	  ≥40.171	  In	  study	  III,	  mean	  BMI	  
varied	  between	  the	  three	  bearing	  groups	  indicating	  that	  BMI	  is	  a	  
confounder.	  But	  information	  on	  height	  and	  weight	  is	  not	  
registered	  in	  the	  DHR	  or	  in	  the	  NARA	  database,	  which	  explains	  that	  
BMI	  is	  not	  adjusted	  for	  in	  study	  I	  and	  II.	  This	  may	  result	  in	  an	  
underestimated	  RR	  of	  revision	  for	  MoM	  compared	  to	  MoP	  THA,	  if	  
patients	  having	  MoM	  THA	  have	  lower	  BMI	  as	  found	  in	  study	  III.	  In	  
contrast,	  BMI	  have	  been	  adjusted	  for	  in	  study	  III.	  Among	  the	  
surgery-­‐related	  factors,	  the	  fixation	  technique	  has	  been	  shown	  to	  
influence	  the	  risk	  of	  revision.16,19	  The	  confounding	  effect	  of	  fixation	  
is	  eliminated	  in	  study	  I	  and	  II,	  because	  only	  cementless	  THAs	  have	  
been	  included,	  whereas	  adjustments	  have	  been	  made	  in	  study	  III.	  
Larger	  femoral	  head	  sizes	  increase	  the	  jump	  distance85	  and	  
decrease	  risk	  of	  revision	  due	  to	  dislocation	  (RR=0.09	  (95%	  CI:	  0.05–
0.17)	  for	  femoral	  head	  sizes	  >36	  mm	  compared	  to	  head	  size	  of	  28	  
mm)29.	  In	  study	  II,	  92%	  of	  MoM	  THAs	  had	  femoral	  head	  sizes	  ≥38	  
mm	  and	  97%	  of	  MoP	  THAs	  had	  head	  sizes	  <38	  mm.	  Therefore,	  
femoral	  head	  size	  was	  considered	  a	  proxy	  for	  the	  bearings	  and	  was	  
not	  adjusted	  for.	  Duration	  of	  surgery,	  which	  may	  reflect	  the	  
surgeon’s	  skills	  and	  the	  complexity	  of	  the	  patient	  case,	  was	  found	  
to	  be	  a	  predictor	  for	  revision	  due	  to	  PJI	  after	  primary	  THA	  (RR=2.0	  
(95%	  CI:	  1.5–2.8)	  for	  duration	  of	  surgery	  longer	  than	  two	  hours	  
compared	  to	  less	  than	  one	  hour)172,	  and	  the	  confounding	  effect	  of	  
duration	  of	  surgery	  was	  reduced	  by	  adjustments	  in	  study	  I,	  but	  
duration	  of	  surgery	  was	  not	  registered	  in	  the	  NARA	  database	  and	  
therefore	  not	  adjusted	  for.	  The	  confounding	  effect	  of	  year	  of	  
surgery	  may	  be	  related	  to	  the	  introduction	  of	  new	  implants	  or	  
bearings	  during	  recent	  years,	  e.g.	  BIOLOX	  Delta	  or	  incorporation	  of	  
vitamin	  E	  in	  HXLPE,	  and	  surgeons	  may	  have	  been	  better	  to	  register	  
data	  in	  the	  DHR	  resulting	  in	  higher	  completeness.	  Also	  the	  
confounding	  effect	  of	  year	  of	  surgery	  was	  reduced	  by	  adjustments.	  
	   Although	  adjusting	  for	  many	  patient-­‐	  and	  treatment-­‐related	  
confounders,	  unmeasured	  confounding	  may	  be	  due	  to	  patient-­‐
related	  prognostic	  factors	  including	  medication	  (postoperative	  use	  
of	  statin	  was	  associated	  with	  lower	  RR	  of	  revision)23;	  alcohol	  use	  
(associated	  with	  non-­‐traumatic	  osteonecrosis	  of	  the	  femoral	  head,	  
and	  this	  diagnosis	  has	  a	  higher	  RR	  of	  revision)173,174;	  smoking	  habits	  
(a	  strong	  association	  between	  smoking	  and	  risk	  of	  revision	  of	  MoM	  
THA	  has	  been	  found)175;	  physical	  activity	  before	  and	  after	  primary	  
surgery	  (some	  predictors	  of	  high	  activity	  at	  5	  years	  after	  surgery	  
were	  younger	  age,	  male	  sex,	  and	  lower	  BMI)166;	  patients’	  
expectations	  (the	  more	  preoperative	  expectations	  the	  patients	  
had,	  the	  more	  likely	  they	  were	  to	  improve	  after	  surgery)156;	  
anxiety	  (preoperative	  depressive	  symptoms	  predicted	  smaller	  
changes	  in	  HOOS	  subscale	  scores	  and	  patients	  were	  less	  satisfied	  
12	  months	  postoperatively)158,176;	  socioeconomic	  factors	  including	  
education	  (high	  educational	  level	  was	  associated	  with	  higher	  
health-­‐related	  QoL	  and	  less	  pain)159.	  Treatment-­‐related	  prognostic	  
factors	  potentially	  leading	  to	  confounding	  include	  surgical	  
approach	  (worse	  scores	  on	  HOOS	  and	  EQ-­‐5D	  were	  reported	  after	  
lateral	  approach	  than	  after	  posterior	  approach,	  and	  lateral	  
approach	  was	  shown	  to	  increase	  the	  risk	  of	  revision	  du	  to	  aseptic	  
loosening	  and	  decrease	  the	  risk	  of	  revision	  due	  to	  
dislocation)31,177,178;	  type	  of	  polyethylene	  as	  both	  cross-­‐linked	  and	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Table	  5.	  Crude	  and	  adjusteda	  RR	  of	  revision	  for	  any	  cause,	  with	  
95%	  CIs,	  in	  THA	  with	  CoC	  and	  MoP	  bearings	  
	   Patients	  in	  
the	  beginning	  









RR	  (95%	  CI)	  
At	  2-­‐year	  follow-­‐up	  (0	  to	  2	  years	  postoperatively)	  
CoC	   1,773	   48	  (2.7)	   0.91	  (0.67-­‐1.24)	  
1.18	  (0.65-­‐
2.13)	  
MoP	   9,323	   274	  (2.9)	   1	  (ref.)	   1	  (ref.)	  
At	  4-­‐year	  follow-­‐up	  (2	  to	  4	  years	  postoperatively)	  
CoC	   1,519	   15	  (1.0)	   0.95	  (0.72-­‐1.26)	  
1.12	  (0.70-­‐
1.81)	  
MoP	   7,065	   62	  (0.9)	   1	  (ref.)	   1	  (ref.)	  
At	  6-­‐year	  follow-­‐up	  (4	  to	  6	  years	  postoperatively)	  
CoC	   1,135	   4	  (0.4)	   0.91	  (0.68-­‐1.21)	  
1.03	  (0.60-­‐
1.77)	  
MoP	   4,501	   26	  (0.6)	   1	  (ref.)	   1	  (ref.)	  
At	  8.7-­‐year	  follow-­‐up	  (6	  to	  8.7	  years	  postoperatively)	  
CoC	   543	   4	  (0.8)	   1.02	  (0.74-­‐1.39)	  
1.33	  (0.72-­‐
2.43)	  
MoP	   2,230	   11	  (0.5)	   1	  (ref.)	   1	  (ref.)	  
aAdjustments	  were	  made	  for	  sex,	  age,	  diagnosis	  of	  primary	  THA,	  
comorbidity,	  year	  of	  surgery,	  femoral	  head	  size,	  and	  duration	  of	  
surgery	  
	  
highly	  cross-­‐linked	  polyethylene	  have	  been	  included	  (the	  use	  of	  
highly	  cross-­‐linked	  polyethylene	  reduces	  polyethylene	  wear	  
substantially)179;	  antibiotic	  and	  thromboembolic	  prophylaxis180-­‐182.	  
The	  structure-­‐related	  prognostic	  factors,	  which	  may	  result	  in	  
confounding,	  include	  hospital	  volume	  (hospitals	  operating	  ≤50	  
procedures	  per	  year	  had	  an	  increased	  risk	  of	  revision	  after	  two-­‐,	  
five-­‐,	  10-­‐,	  and	  15-­‐year	  follow-­‐up)32;	  set-­‐up	  including	  fast-­‐track33;	  
surgeon’s	  skills	  including	  learning-­‐curve	  and	  positioning	  of	  
components183-­‐185;	  operation	  theatre	  (airflow,	  plastic	  adhesive	  
draping,	  separate	  skin	  and	  deep	  knives)186.	  Furthermore,	  
information	  from	  any	  radiological	  examinations	  including	  MRI	  and	  
blood	  concentrations	  of	  chromium	  and	  cobalt	  may	  also	  be	  
prognostic	  factors.	  Except	  from	  blood	  concentrations	  of	  chromium	  
and	  cobalt	  and	  results	  of	  MRIs	  and	  ultrasound	  examinations,	  which	  
have	  been	  included	  in	  the	  DHR	  since	  2013	  for	  MoM	  THA,	  none	  of	  





Risk	  of	  any	  revision	  
11,096	  patients	  having	  cementless	  THA	  with	  CoC	  (n=1,773	  (16%))	  
and	  MoP	  (n=9,323	  (84%))	  bearings	  were	  included.	  The	  median	  
follow-­‐up	  was	  5.0	  (interquartile	  range	  (IQR):	  3.1-­‐6.5)	  years	  for	  CoC	  
and	  3.9	  (IQR:	  2.0-­‐5.9)	  years	  for	  MoP	  bearings	  (p<0.001	  based	  on	  a	  
Wilcoxon	  rank-­‐sum	  test).	  The	  entire	  study	  population	  had	  444	  
revisions	  (4.0%):	  4.0%	  (71	  of	  1,773)	  for	  CoC	  THA	  and	  4.0%	  (373	  of	  
9,323)	  for	  MoP	  THA.	  At	  8.7-­‐year	  follow-­‐up,	  the	  cumulative	  
incidence	  for	  any	  revision	  was	  5.4%	  (95%	  CI:	  4.0-­‐7.1)	  for	  CoC	  THA	  
and	  5.3%	  (95%	  CI:	  4.7-­‐5.9)	  for	  MoP	  THA.	  No	  significant	  difference	  
in	  the	  RR	  of	  revision	  for	  any	  cause	  was	  found	  for	  CoC	  THA	  
compared	  to	  MoP	  THA	  at	  two-­‐,	  four-­‐,	  six-­‐,	  and	  8.7-­‐year	  follow-­‐up	  
(Table	  5).	  
	  
Causes	  of	  revision	  
Eight	  CoC	  THAs	  were	  revised	  due	  to	  component	  failure.	  The	  
proportion	  of	  revision	  due	  to	  component	  failure	  was	  higher	  for	  
CoC	  than	  for	  MoP	  bearings	  (p<0.001	  based	  on	  a	  chi-­‐square	  test)	  
(Table	  6).	  Of	  the	  eight	  patients	  registered	  with	  component	  failure	  
as	  revision	  cause,	  six	  (0.34%)	  patients	  had	  ceramic	  fracture	  and	  
two	  (0.11%)	  patients	  had	  impingement	  between	  the	  stem-­‐neck	  
and	  the	  rim	  of	  the	  liner.	  No	  statistically	  significant	  difference	  in	  the	  
risk	  of	  revision	  due	  to	  aseptic	  loosening	  (adjusted	  RR	  0.84,	  95%	  CI:	  
0.21-­‐3.4),	  dislocation	  (adjusted	  RR	  1.2,	  95%	  CI:	  0.29-­‐5.3),	  and	  all	  
other	  revision	  causes	  (adjusted	  RR	  1.1,	  95%	  CI:	  0.14-­‐8.8)	  was	  found	  




Table	  6.	  Main	  indications	  for	  THA	  revision	  registered	  in	  the	  DHR.	  
For	  CoC	  and	  MoP	  bearings,	  the	  number	  and	  percentage	  (%)	  for	  the	  
specific	  cause	  of	  revision	  is	  given	  





Aseptic	  loosening	   10	  (0.6)	   43	  (0.5)	   0.6	  
Osteolysis	  without	  loosening	   0	  (0.0)	   3	  (0.0)	   0.5	  
Deep	  infection	   6	  (0.3)	   61	  (0.7)	   0.1	  
Femoral	  bone	  fracture	   9	  (0.5)	   56	  (0.6)	   0.6	  
Dislocation	   22	  (1.2)	   156	  (1.7)	   0.2	  
Component	  failure	   8	  (0.5)	   6	  (0.1)	   <0.001	  
Pain	   9	  (0.5)	   26	  (0.3)	   0.1	  
	  
Table	  7.	  Crude	  and	  adjusteda	  RR	  of	  revision	  for	  any	  cause,	  with	  
95%	  CIs,	  in	  THA	  with	  MoM	  and	  MoP	  bearings	  
	   Patients	  in	  
the	  
beginning	  of	  










At	  1-­‐year	  follow-­‐up	  (0	  to	  1	  year	  postoperatively)	  
MoM	   11,567	   198	  (1.7)	   0.81	  (0.68-­‐0.95)	  
0.83	  (0.70-­‐
1.00)	  
MoP	   21,111	   448	  (2.1)	   1	  (ref.)	   1	  (ref.)	  
At	  2-­‐year	  follow-­‐up	  (1	  to	  2	  years	  postoperatively)	  
MoM	   11,295	   91	  (0.8)	   0.92	  (0.80-­‐1.06)	  
0.94	  (0.81-­‐
1.09)	  
MoP	   20,495	   123	  (0.6)	   1	  (ref.)	   1	  (ref.)	  
At	  3-­‐year	  follow-­‐up	  (2	  to	  3	  years	  postoperatively)	  
MoM	   9,640	   66	  (0.7)	   1.01	  (0.89-­‐1.15)	  
1.02	  (0.89-­‐
1.18)	  
MoP	   15,653	   72	  (0.5)	   1	  (ref.)	   1	  (ref.)	  
At	  4-­‐year	  follow-­‐up	  (3	  to	  4	  years	  postoperatively)	  
MoM	   7,251	   44	  (0.6)	   1.09	  (0.96-­‐1.23)	  
1.10	  (0.96-­‐
1.26)	  
MoP	   11,976	   45	  (0.4)	   1	  (ref.)	   1	  (ref.)	  
At	  5-­‐year	  follow-­‐up	  (4	  to	  5	  years	  postoperatively)	  
MoM	   4,638	   49	  (1.1)	   1.32	  (1.17-­‐1.50)	  
1.37	  (1.19-­‐
1.57)	  
MoP	   9,137	   22	  (0.2)	   1	  (ref.)	   1	  (ref.)	  
At	  6-­‐year	  follow-­‐up	  (5	  to	  6	  years	  postoperatively)	  
MoM	   2,466	   18	  (0.7)	   1.44	  (1.27-­‐1.63)	  
1.49	  (1.30-­‐
1.71)	  
MoP	   6,811	   19	  (0.3)	   1	  (ref.)	   1	  (ref.)	  
aAdjustments	  were	  made	  for	  sex,	  age,	  and	  diagnosis	  of	  primary	  
THA	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The	  study	  population	  included	  32,678	  patients	  having	  cementless	  
stemmed	  THA	  with	  MoM	  (n=11,567	  (35%))	  and	  MoP	  (n=21,111	  
(65%))	  THAs.	  The	  median	  follow-­‐up	  was	  3.6	  (IQR:	  2.4-­‐4.8)	  years	  for	  
MoM	  and	  3.4	  (IQR:	  2.0-­‐5.8)	  years	  for	  MoP	  bearings	  (p<0.001	  based	  
on	  a	  Wilcoxon	  rank-­‐sum	  test).	  1,236	  (3.8%	  of	  32,678	  patients)	  first	  
time	  revisions	  following	  primary	  THA	  were	  registered	  during	  the	  
study	  period:	  4.1%	  (470	  of	  11,567	  patients)	  for	  MoM	  and	  3.6%	  
(766	  of	  21,111	  patients)	  for	  MoP	  bearings.	  The	  cumulative	  
incidence	  of	  any	  revision	  was	  7.0%	  (95%	  CI:	  6.0-­‐8.1)	  for	  MoM	  and	  
5.1%	  (95%	  CI:	  4.7-­‐5.6)	  for	  MoP	  at	  eight-­‐year	  follow-­‐up.	  The	  RR	  of	  
any	  revision	  was	  statistically	  significantly	  increased	  for	  MoM	  after	  
five-­‐	  and	  six-­‐year	  follow-­‐up	  (Table	  7).	  
	  
Stratified	  analyses	  and	  causes	  of	  revision	  
The	  MoM	  cup/stem	  combinations	  of	  Articular	  Surface	  
Replacement	  (ASR)/Summit,	  ASR/Corail,	  and	  “other”	  had	  
statistically	  significantly	  higher	  RR	  of	  revision	  for	  any	  reason	  
compared	  to	  MoP	  THAs	  (Table	  8).	  The	  cementless	  MoM	  THAs	  had	  
higher	  proportion	  of	  revisions	  due	  to	  aseptic	  loosening	  (p<0.001	  
based	  on	  a	  chi-­‐square	  test)	  and	  “other”	  causes	  (p=0.03	  based	  on	  a	  
chi-­‐square	  test).	  A	  lower	  frequency	  of	  revisions	  due	  to	  dislocation	  
(p<0.001	  based	  on	  a	  chi-­‐square	  test)	  was	  found	  for	  MoM	  THA	  
regardless	  of	  femoral	  head	  size	  compared	  to	  MoP	  THAs.	  At	  six-­‐year	  
follow-­‐up,	  the	  RR	  of	  revision	  due	  to	  dislocation	  was	  lower	  (0.27,	  
95%	  CI:	  0.19-­‐0.39)	  for	  MoM	  than	  for	  MoP	  bearings,	  but	  the	  RR	  of	  
revision	  due	  to	  aseptic	  loosening	  (5.5,	  95%	  CI:	  3.8-­‐7.9)	  and	  all	  
other	  revision	  causes	  (1.2,	  95%	  CI:	  1.0-­‐1.5)	  was	  higher	  when	  	  
	  
Table	  8.	  Median	  follow-­‐up	  for	  combination	  of	  acetabular	  and	  femoral	  components	  in	  MoM	  THA.	  Crude	  and	  adjusteda	  RR	  of	  revision	  for	  
any	  cause	  at	  six-­‐year	  follow-­‐up	  with,	  95%	  CIs,	  compared	  to	  MoP	  THA.	  
	   n=32,678	  (%)	   Median	  follow-­‐up	  
(IQR)	  




All	  MoP	  THAs	   21,111	  (65)	   3.4	  (2.0-­‐5.8)	   766	   1	  (ref.)	   1	  (ref.)	  
Recap/Bi-­‐Metric	   4,990	  (15)	   3.2	  (2.2-­‐4.4)	   138	   0.90	  (0.76-­‐1.06)	   0.96	  (0.80-­‐1.15)	  
M2a/Bi-­‐Metric	  	   2,407	  (7)	   4.8	  (3.0-­‐6.1)	   95	   1.16	  (0.87-­‐1.53)	   1.25	  (0.93-­‐1.67)	  
Pinnacle/Corail	   910	  (3)	   2.9	  (2.0-­‐3.9)	   31	   1.21	  (0.89-­‐1.65)	   1.25	  (0.90-­‐1.74)	  
Conserve	  Plus/Profemur	   418	  (1)	   3.2	  (2.7-­‐3.9)	   18	   1.53	  (1.00-­‐2.33)	   1.47	  (0.95-­‐2.27)	  
ASR/Summit	  	   401	  (1)	   3.9	  (2.8-­‐4.8)	   56	   6.35	  (4.74-­‐8.49)	   7.27	  (5.18-­‐10.2)	  
Birmingham/Synergy	  	   369	  (1)	   4.2	  (3.4-­‐5.1)	   10	   1.07	  (0.51-­‐2.24)	   1.26	  (0.56-­‐2.84)	  
ASR/Corail	  	   307	  (1)	   3.7	  (2.7-­‐4.5)	   35	   5.00	  (3.54-­‐7.07)	   5.17	  (3.53-­‐7.56)	  
Others	  	   1,765	  (6)	   3.7	  (2.5-­‐4.9)	   87	   1.77	  (1.39-­‐2.26)	   1.75	  (1.29-­‐2.36)	  
aAdjustments	  were	  made	  for	  sex,	  age,	  and	  diagnosis	  of	  primary	  THA	  
	  
Table	  9.	  Association	  between	  experience	  of	  noise	  from	  THA	  with	  CoC,	  MoM,	  and	  MoP	  bearings	  and	  mean	  differences	  of	  PROM	  subscales	  
with	  95%	  CIs	  








HOOS	  Symptoms	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐12.9	  (-­‐14.9	  to	  -­‐10.8)	   -­‐11.4	  (-­‐15.2	  to	  -­‐7.65)	   -­‐16.8	  (-­‐20.6	  to	  -­‐13.0)	   0	  (ref.)	  
	   Adjusted	   -­‐13.6	  (-­‐15.8	  to	  -­‐11.4)	   -­‐12.0	  (-­‐16.2	  to	  -­‐7.83)	   -­‐16.1	  (-­‐20.0	  to	  -­‐12.2)	   0	  (ref.)	  
HOOS	  Pain	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐7.33	  (-­‐9.21	  to	  -­‐5.45)	   -­‐5.11	  (-­‐8.31	  to	  -­‐1.90)	   -­‐14.0	  (-­‐18.1	  to	  -­‐9.97)	   0	  (ref.)	  
	   Adjusted	   -­‐7.79	  (-­‐10.0	  to	  -­‐5.59)	   -­‐5.11	  (-­‐8.56	  to	  -­‐1.67)	   -­‐13.4	  (-­‐17.5	  to	  -­‐9.37)	   0	  (ref.)	  
HOOS	  ADL	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐7.29	  (-­‐9.63	  to	  -­‐4.95)	   -­‐5.52	  (-­‐9.19	  to	  -­‐1.84)	   -­‐14.2	  (-­‐18.3	  to	  -­‐10.1)	   0	  (ref.)	  
	   Adjusted	   -­‐8.53	  (-­‐11.2	  to	  -­‐5.89)	   -­‐7.58	  (-­‐11.8	  to	  -­‐3.40)	   -­‐13.6	  (-­‐17.9	  to	  -­‐9.27)	   0	  (ref.)	  
HOOS	  Sport	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐9.45	  (-­‐13.0	  to	  -­‐5.94)	   -­‐7.16	  (-­‐11.8	  to	  -­‐2.47)	   -­‐21.2	  (-­‐26.9	  to	  -­‐15.5)	   0	  (ref.)	  
	   Adjusted	   -­‐11.3	  (-­‐15.6	  to	  -­‐7.13)	   -­‐11.6	  (-­‐17.8	  to	  -­‐5.44)	   -­‐19.7	  (-­‐25.4	  to	  -­‐13.9)	   0	  (ref.)	  
HOOS	  QoL	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐12.1	  (-­‐15.0	  to	  -­‐9.24)	   -­‐12.3	  (-­‐16.8	  to	  -­‐7.76)	   -­‐20.1	  (-­‐24.6	  to	  -­‐15.5)	   0	  (ref.)	  
	   Adjusted	   -­‐11.8	  (-­‐14.7	  to	  -­‐8.94)	   -­‐12.2	  (-­‐17.3	  to	  -­‐7.10)	   -­‐19.1	  (-­‐24.0	  to	  -­‐14.3)	   0	  (ref.)	  
EQ-­‐5D	  index	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐0.059	  (-­‐0.085	  to	  -­‐0.032)	   -­‐0.067	  (-­‐0.100	  to	  -­‐0.034)	   -­‐0.113	  (-­‐0.144	  to	  -­‐0.081)	   0	  (ref.)	  
	   Adjusted	   -­‐0.061	  (-­‐0.088	  to	  -­‐0.035)	   -­‐0.073	  (-­‐0.117	  to	  -­‐0.030)	   -­‐0.108	  (-­‐0.137	  to	  -­‐0.079)	   0	  (ref.)	  
EQ	  VAS	   	   	   	   	   	  
Mean	  difference	   Crude	   -­‐3.07	  (-­‐5.80	  to	  –0.38)	   -­‐2.81	  (-­‐6.63	  to	  1.01)	   -­‐9.99	  (-­‐14.5	  to	  -­‐5.51)	   0	  (ref.)	  
	   Adjusted	   -­‐4.56	  (-­‐7.20	  to	  -­‐1.92)	   -­‐6.29	  (-­‐9.72	  to	  -­‐2.87)	   -­‐9.44	  (-­‐13.5	  to	  -­‐5.38)	   0	  (ref.)	  
UCLA	  activity	  score	   	   	   	   	   	  
Mean	  difference	   Crude	   0.08	  (-­‐0.20	  to	  0.35)	   0.16	  (-­‐0.16	  to	  0.47)	   -­‐0.53	  (-­‐0.89	  to	  -­‐0.17)	   0	  (ref.)	  
	   Adjusted	   -­‐0.12	  (-­‐0.38	  to	  0.15)	   -­‐0.44	  (-­‐0.88	  to	  0.00)	   -­‐0.56	  (-­‐0.88	  to	  -­‐0.25)	   0	  (ref.)	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comparing	  MoM	  to	  MoP	  bearings.	  
	  
Study	  III	  
Comparison	  between	  bearing	  groups	  
The	  response	  rate	  was	  85%	  (3,089	  of	  3,625).	  In	  the	  study	  
population	  (n=3,089),	  45%	  received	  CoC,	  17%	  MoM,	  and	  38%	  MoP	  
THA.	  There	  was	  similar	  distribution	  of	  sex	  within	  the	  three	  bearing	  
groups:	  44-­‐46%	  were	  females,	  and	  54-­‐56%	  were	  males	  (p=0.68	  
based	  on	  a	  chi-­‐square	  test).	  Mean	  age	  difference	  was	  -­‐1.6	  (95%	  CI:	  
-­‐2.3	  to	  -­‐1.0)	  years	  for	  CoC	  and	  -­‐1.9	  (95%	  CI:	  -­‐2.7	  to	  -­‐1.0)	  years	  for	  
MoM	  THA	  compared	  to	  patients	  with	  MoP	  THA.	  Mean	  follow-­‐up	  
was	  6.9	  years	  for	  CoC	  and	  MoP	  THA	  and	  5.1	  years	  for	  MoM	  THA.	  
For	  HOOS	  Symptoms,	  the	  adjusted	  mean	  score	  was	  significantly	  
lower	  for	  the	  CoC	  group	  compared	  to	  the	  MoP	  group	  (adjusted	  
mean	  difference	  (aMD)	  -­‐2.3	  (95%	  CI,	  -­‐4.1	  to	  -­‐0.5)).	  No	  other	  
statistical	  significant	  adjusted	  differences	  were	  found	  for	  the	  other	  
HOOS	  subscales,	  EQ-­‐5D	  index,	  EQ-­‐5D	  VAS,	  or	  UCLA	  activity	  score	  
when	  comparing	  the	  CoC	  and	  MoM	  groups	  to	  the	  MoP	  group.	  
	  
Noises	  
27%	  of	  patients	  with	  CoC,	  29%	  of	  patients	  with	  MoM,	  and	  12%	  of	  
patients	  with	  MoP	  bearings	  had	  experienced	  noises	  from	  the	  THA.	  
Stratified	  analyses	  for	  the	  three	  types	  of	  bearings	  with	  and	  without	  
noises	  showed	  significantly	  lower	  adjusted	  mean	  scores	  of	  all	  
HOOS	  subscales,	  EQ-­‐5D	  index,	  and	  EQ-­‐5D	  VAS	  for	  patients	  
experiencing	  noises	  from	  the	  CoC,	  MoM	  or	  MoP	  THA	  compared	  to	  
patients	  having	  MoP	  THA	  without	  noises.	  For	  all	  subscales,	  the	  
aMD	  was	  largest	  for	  MoP	  THA	  with	  noises.	  Only	  for	  the	  ULCA	  
activity	  score,	  no	  difference	  was	  found	  for	  CoC	  and	  MoM	  THA	  with	  
noises	  compared	  to	  MoP	  THA	  without	  noises	  (Table	  9).	  
	  
DISCUSSION	  
Discussion	  of	  bearings	  
When	  the	  surgeon	  together	  with	  the	  patients	  shall	  choose	  the	  
couple	  of	  bearings,	  pros	  and	  cons	  may	  be	  weighted.	  MoP	  bearings	  
were	  introduced	  in	  the	  Charnley	  era	  and	  are	  still	  the	  most	  
commonly	  used	  bearings.	  Hence,	  the	  clinical	  experience	  with	  these	  
bearings	  is	  very	  long,	  and	  MoP	  THA	  may	  be	  considered	  a	  safe	  
treatment.	  The	  most	  prominent	  challenge	  with	  MoP	  bearings	  has	  
been	  wear	  and	  generation	  of	  polyethylene	  wear	  particles	  possibly	  
resulting	  in	  osteolysis	  and	  aseptic	  loosening	  of	  the	  implant,	  if	  wear	  
rate	  is	  too	  high.	  However,	  the	  newer	  generations	  of	  polyethylene	  
have	  shown	  promising	  durability	  as	  regards	  wear.179,187	  From	  CoC	  
bearings,	  there	  are	  fewer	  wear	  particles	  generated	  and	  these	  are	  
supposed	  to	  be	  more	  bioinert	  than	  polyethylene	  wear	  particles,	  
which	  may	  reduce	  the	  problem	  with	  aseptic	  loosening.	  On	  the	  
other	  hand,	  the	  risk	  with	  CoC	  bearings	  is	  fracture	  of	  the	  head	  or	  
insert	  which	  is	  a	  serious	  complication.	  In	  study	  I,	  the	  prevalence	  of	  
revision	  due	  to	  ceramic	  fracture	  was	  0.34%,	  which	  is	  in	  accordance	  
with	  a	  study	  by	  Traina	  et	  al.,	  who	  reported	  a	  prevalence	  of	  ceramic	  
fracture	  of	  0.5%188.	  Ceramic	  fracture	  is	  a	  serious	  complication	  
because	  there	  is	  a	  high	  risk	  of	  more	  than	  one	  revision	  following	  
ceramic	  fracture.189	  There	  exist	  no	  consensus	  about	  the	  best	  
strategy	  for	  revision	  surgery	  in	  patients	  with	  ceramic	  fracture73	  
although	  it	  has	  been	  recommended	  to	  implant	  CoC	  or	  ceramic-­‐on-­‐
polyethylene	  (CoP)	  bearings.188	  A	  high	  complication	  rate	  was	  seen	  
by	  Lee	  et	  al.	  when	  using	  MoP	  bearings	  during	  revision	  for	  ceramic	  
fracture.190	  Another	  drawback	  to	  take	  into	  account	  in	  relation	  to	  
CoC	  bearings	  is	  noises.	  Noises	  have	  been	  described	  particularly	  
from	  CoC	  bearings152,191,192,	  but	  in	  study	  III	  it	  is	  revealed,	  that	  the	  
prevalence	  of	  self-­‐reported	  noises	  from	  both	  CoC	  and	  MoM	  THA	  is	  
high	  (27-­‐29%),	  whereas	  noises	  from	  MoP	  THA	  were	  prevalent	  in	  
12%.	  The	  reported	  high	  frequency	  of	  noises	  question,	  what	  the	  
patient	  in	  fact	  report	  as	  a	  noise.	  But	  it	  seems	  to	  bother	  the	  
patients	  reporting	  noises,	  as	  noisy	  THAs	  resulted	  in	  lower	  PROM	  
scores	  compared	  to	  silent	  MoP	  THAs	  in	  study	  III,	  thus	  indicating	  
that	  noises	  from	  the	  THA	  may	  be	  of	  clinical	  significance.	  CoC	  
bearings	  are	  recommended	  by	  some	  authors	  to	  be	  used	  in	  young	  
and	  active	  patients167,	  and	  as	  found	  in	  study	  I,	  patients	  with	  CoC	  
were	  younger	  than	  patients	  with	  MoP	  demonstrating	  that	  patients	  
are	  selected	  to	  this	  bearing.	  This	  had,	  however,	  no	  influence	  on	  
the	  activity	  level,	  which	  was	  similar	  for	  patients	  with	  CoC	  and	  MoP	  
bearings	  after	  mean	  follow-­‐up	  of	  6.9	  years	  (study	  III).	  Some	  
surgeons	  may	  reserve	  CoC	  bearings	  to	  a	  highly	  selected	  group	  of	  
very	  young	  patients	  suffering	  from	  childhood	  hip	  disorder.	  
Hannouche	  et	  al.	  published	  a	  series	  of	  105	  CoC	  THAs	  in	  patients	  
younger	  than	  20	  years	  at	  the	  time	  of	  primary	  THA,	  and	  the	  10-­‐year	  
survival	  rate	  with	  aseptic	  loosening	  as	  endpoint	  was	  90.3%	  (95%	  
CI:	  82.4%–98.9%).168	  
	   Since	  2012	  the	  use	  of	  MoM	  bearings	  has	  been	  abandoned	  in	  
Denmark	  because	  of	  the	  concerns	  for	  the	  long-­‐term	  prognosis.	  The	  
higher	  risk	  of	  revision	  of	  MoM	  compared	  to	  MoP	  THA	  was	  
confirmed	  in	  study	  II.	  However,	  PROM	  scores	  from	  patients	  having	  
MoM	  THA	  were	  similar	  to	  PROM	  scores	  from	  patients	  having	  MoP	  
THAs,	  which	  may	  be	  due	  to	  revision	  of	  the	  unsuccessful	  MoM	  THA	  
(study	  III).	  	  
	   Another	  thing	  to	  account	  for	  when	  choosing	  the	  bearings	  for	  
the	  patient	  is	  the	  cost-­‐effectiveness,	  as	  CoC	  and	  MoM	  bearings	  in	  
general	  are	  more	  expensive	  than	  MoP	  bearings.	  However,	  
Pulikottil-­‐Jacob	  et	  al.	  reported	  that	  the	  differences	  in	  quality-­‐
adjusted	  life-­‐years	  between	  different	  bearings	  and	  fixation	  
methods	  were	  extremely	  small.	  It	  was	  recommended	  that	  the	  
choice	  of	  prosthesis	  should	  be	  determined	  by	  the	  rate	  of	  revision,	  
local	  costs	  and	  the	  preferences	  of	  the	  surgeon	  and	  patient.15	  
	   MoP	  are	  still	  considered	  “standard”	  bearings	  by	  most	  
surgeons.193,194	  CoC	  bearings	  may	  be	  recommended	  in	  younger	  
patients,	  whereas	  the	  use	  of	  MoM	  bearings	  is	  not	  recommended,	  
before	  population-­‐based	  studies	  with	  long-­‐term	  follow-­‐up	  have	  
shown	  similar	  survival	  as	  for	  CoC	  and	  MoP	  bearings.	  In	  addition,	  
CoP	  bearings	  were	  found	  to	  have	  lower	  13-­‐year	  HR=0.80	  (95%	  CI:	  
0.74-­‐0.88)	  for	  any	  revision	  compared	  to	  MoP	  THA16,	  but	  
population-­‐based	  studies	  are	  lacking.	  
	  
Choice	  of	  outcome	  
This	  thesis	  has	  focused	  on	  the	  association	  between	  bearings	  and	  
the	  risk	  of	  revision	  and	  PROs	  but	  in	  relation	  to	  THA,	  several	  
outcomes	  may	  be	  of	  relevance:	  Radiological	  findings,	  metal-­‐ion	  
levels,	  second	  revision,	  economy,	  and	  mortality.	  When	  asking	  a	  
scientific	  question,	  the	  chosen	  outcome	  shall	  be	  appropriate	  to	  
give	  an	  answer.	  In	  study	  I	  and	  II,	  the	  outcome	  was	  firstly	  revision	  
for	  any	  and	  secondly	  for	  specific	  causes.	  Studies	  on	  implant	  
survival	  or	  annual	  reports	  from	  hip	  arthroplasty	  registries	  answer	  
the	  question:	  “What	  is	  the	  longevity	  of	  the	  implant?”,	  but	  from	  
these	  studies	  it	  is	  not	  possible	  to	  answer:	  “What	  is	  the	  QoL	  after	  
THA?”	  However,	  survival	  studies	  are	  very	  important	  to	  identify	  any	  
early	  failure	  of	  a	  new	  implants,	  as	  the	  lost	  survival	  will	  never	  be	  
regained	  with	  longer	  follow-­‐up.	  This	  is	  illustrated	  in	  study	  II	  and	  
other	  studies	  reporting	  lower	  survival	  rates	  for	  MoM	  THA105,107.	  If	  
THA	  is	  only	  defined	  as	  a	  failure,	  when	  the	  implant	  is	  revised,	  the	  
patient	  with	  a	  poor	  outcome	  and	  no	  awaiting	  revision	  surgery	  will	  
not	  be	  captured,	  which	  results	  in	  an	  overestimation	  of	  the	  success	  
of	  the	  THA.11	  Therefore,	  PROMs	  shall	  be	  used	  in	  combination	  with	  
survival	  in	  order	  to	  give	  a	  more	  balanced	  and	  real	  measure	  of	  the	  
success	  after	  THA.	  	  
	   In	  study	  III,	  the	  outcome	  was	  disease-­‐specific	  and	  generic	  
PROM	  scores	  and	  noises	  from	  the	  THA,	  as	  the	  aim	  was	  to	  examine	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if	  type	  of	  bearings	  was	  a	  prognostic	  factor	  for	  PROM	  scores	  and	  
noises.	  Only	  a	  few	  studies	  have	  reported	  the	  influence	  of	  type	  of	  
bearings	  on	  PROM	  scores111,195,	  but	  one	  could	  argue	  that	  PROMs	  
are	  too	  coarse	  to	  possibly	  answer,	  if	  there	  might	  be	  difference	  in	  
the	  patients’	  perception	  of	  THA	  with	  different	  types	  of	  bearings.	  	  
	  
Results	  compared	  to	  other	  studies	  
Ceramic-­‐on-­‐ceramic	  total	  hip	  arthroplasty	  
The	  main	  concerns	  of	  CoC	  are	  fracture	  of	  the	  components	  whereas	  
reduced	  wear	  is	  an	  advantage.	  This	  may	  in	  the	  long-­‐term	  run	  result	  
in	  fewer	  revisions	  compared	  to	  MoP	  bearings.	  NJR	  is	  the	  registry	  
with	  the	  largest	  number	  of	  CoC	  THA	  registered,	  and	  the	  
cumulative	  incidence	  of	  revision	  of	  any	  cause	  was	  4.22%	  (95%	  CI:	  
3.85-­‐4.62)	  at	  10-­‐year	  follow-­‐up.	  This	  was	  lower	  than	  in	  study	  I,	  
where	  we	  found	  a	  cumulative	  incidence	  of	  revision	  of	  5.4%	  (95%	  
CI:	  4.0–7.1)	  for	  CoC	  at	  8.7-­‐year	  follow-­‐up.	  When	  comparing	  the	  HR	  
for	  revision	  of	  any	  cause,	  the	  HR	  for	  CoC	  compared	  to	  MoP	  THA	  
was	  0.81	  (95%	  CI:	  0.70-­‐0.94)	  after	  13-­‐year	  follow-­‐up	  in	  the	  DHR16,	  
whereas	  the	  HR	  for	  CoC	  compared	  to	  metal-­‐on-­‐highly	  cross-­‐linked	  
polyethylene	  (MoHXLPE)	  in	  the	  Australian	  Orthopaedic	  Association	  
National	  Joint	  Replacement	  Registry	  (AOA	  NJRR)	  was	  1.08	  (95%	  CI:	  
1.02-­‐1.14)	  after	  14-­‐year	  follow-­‐up193.	  The	  differences	  in	  HR	  from	  
these	  two	  registries	  may	  be	  due	  to	  inclusion	  of	  both	  conventional	  
and	  highly	  cross-­‐linked	  polyethylene	  in	  the	  analyses	  from	  the	  DHR.	  
These	  findings	  are	  in	  contrast	  to	  those	  in	  study	  I,	  where	  no	  
difference	  in	  RR	  of	  revision	  was	  found	  for	  CoC	  compared	  to	  MoP	  
THA.	  This	  might	  be	  due	  to	  shorter	  follow-­‐up	  and	  better	  
adjustments	  for	  confounding	  in	  our	  study.	  In	  another	  study	  based	  
on	  data	  from	  six	  national	  and	  regional	  registries,	  cementless	  CoC	  
THA	  with	  femoral	  head	  sizes	  >28	  mm	  had	  similar	  risk	  of	  revision	  as	  
MoHXLPE	  THA	  after	  nine-­‐year	  follow-­‐up,	  but	  CoC	  THA	  with	  
femoral	  head	  ≤28	  mm	  had	  increased	  risk	  of	  revision	  (HR=1.36	  (95%	  
CI:	  1.09-­‐1.68)).106	  This	  was	  in	  contrast	  to	  study	  I,	  where	  no	  
difference	  in	  RR	  of	  any	  revision	  was	  found	  for	  any	  femoral	  head	  
size	  ≤28	  mm	  or	  >28	  mm.	  Furthermore,	  a	  meta-­‐analysis	  including	  
18	  randomised	  clinical	  trials	  having	  a	  minimum	  two-­‐year	  follow-­‐up	  
and	  an	  average	  age	  younger	  than	  65	  years	  in	  the	  included	  studies	  
found	  no	  difference	  in	  risk	  ratio	  for	  revision	  of	  CoC	  THA	  when	  
compared	  to	  MoHXLPE.196	  Hence,	  these	  results	  are	  in	  accordance	  
with	  study	  I.	  
	   The	  risk	  of	  revision	  due	  to	  dislocation	  later	  than	  one	  year	  
after	  index	  surgery	  after	  median	  follow-­‐up	  of	  seven	  (range:	  1-­‐13)	  
years	  was	  examined	  in	  a	  study	  from	  the	  New	  Zealand	  Joint	  
Registry	  including	  8,177	  CoC	  THAs.	  In	  patients	  younger	  than	  65	  
years	  having	  28	  mm	  femoral	  heads,	  more	  revisions	  for	  late	  
dislocation	  was	  found	  for	  CoC	  THAs	  compared	  to	  MoM	  THAs	  
(p=0.014),	  whereas	  no	  other	  statistically	  significant	  differences	  
were	  found	  for	  CoC	  THAs	  when	  stratified	  by	  age	  and	  head	  size.197	  
In	  study	  I,	  no	  difference	  in	  RR	  of	  revision	  due	  to	  dislocation	  was	  
found	  for	  CoC	  compared	  to	  MoP	  THA,	  but	  no	  stratification	  for	  
femoral	  head	  size	  was	  made.	  Furthermore,	  other	  differences	  in	  
causes	  of	  revision	  were	  examined	  in	  study	  I,	  and	  we	  found	  a	  higher	  
frequency	  of	  revision	  due	  to	  component	  failure	  for	  CoC	  than	  for	  
MoP	  bearings	  (p<0.001).	  
	   The	  weakness	  of	  the	  current	  knowledge	  of	  CoC	  bearings	  is	  the	  
relatively	  short	  follow-­‐up.	  A	  difference	  in	  revision	  rate	  between	  
MoP	  and	  CoC	  may	  first	  become	  evident	  after	  15	  to	  20	  years	  due	  to	  
the	  very	  low	  wear	  in	  the	  new	  generations	  of	  polyethylene.	  Thus,	  
patients	  who	  may	  benefit	  from	  CoC	  THA	  may	  be	  relatively	  young	  
with	  a	  life	  expectancy	  longer	  than	  15	  to	  20	  years.	  
	  
Metal-­‐on-­‐metal	  total	  hip	  arthroplasty	  
MoM	  bearings	  in	  THA	  were	  reintroduced	  as	  alternative	  bearings	  to	  
MoP.	  Although	  one	  advantage	  is	  the	  possibility	  to	  use	  large	  head	  
sizes	  and	  the	  following	  reduced	  the	  risk	  of	  dislocation,	  there	  major	  
concern	  is	  related	  to	  increased	  risk	  of	  revision.	  In	  the	  NJR,	  the	  
cumulative	  incidence	  of	  revision	  was	  12.7%	  (12.3-­‐13.2)	  at	  seven-­‐
year	  and	  20.2%	  (95%	  CI:	  19.2-­‐21.2)	  at	  10-­‐year	  follow-­‐up.194	  These	  
cumulative	  incidences	  are	  higher	  than	  that	  of	  7.0%	  (95%	  CI:	  6.0–
8.1)	  for	  MoM	  at	  eight	  years	  found	  in	  study	  II,	  and	  these	  differences	  
may	  be	  caused	  by	  the	  use	  of	  different	  component	  designs.	  In	  the	  
AOA	  NJRR,	  the	  HR	  of	  any	  revision	  was	  1.36	  (95%	  CI:	  1.21-­‐1.54)	  
after	  14	  years.193	  This	  is	  in	  accordance	  with	  results	  in	  study	  II	  
where	  the	  RR	  of	  revision	  was	  1.49	  (95%	  CI:	  1.30–1.71),	  although	  
the	  follow-­‐up	  was	  only	  six	  years.	  Furnes	  et	  al.	  published	  a	  study	  
with	  seven-­‐year	  follow-­‐up	  including	  data	  from	  six	  national	  and	  
regional	  registries,	  and	  a	  significantly	  increased	  HR=2.15	  (95%	  CI:	  
1.63-­‐2.83)	  was	  found	  for	  MoM	  THA	  with	  femoral	  head	  size	  >36	  
mm	  compared	  to	  MoHXLPE	  in	  patients	  aged	  from	  45-­‐64	  years.28	  
Furnes	  et	  al.	  had	  excluded	  patients	  with	  the	  ASR	  acetabular	  
component.	  When	  patients	  having	  the	  ASR	  acetabular	  component	  
were	  excluded	  in	  study	  II,	  no	  difference	  in	  RR	  for	  any	  revision	  was	  
found	  for	  MoM	  compared	  to	  MoP	  THA	  at	  six-­‐year	  follow-­‐up.	  In	  
study	  II,	  both	  cross-­‐linked	  and	  highly	  cross-­‐linked	  polyethylene	  was	  
included.	  As	  revision	  rates	  for	  metal-­‐on-­‐conventional	  polyethylene	  
are	  higher	  than	  that	  for	  MoHXLPE193,	  the	  revision	  rate	  for	  MoP	  
THA	  in	  study	  II	  may	  be	  higher	  than	  in	  the	  study	  by	  Furnes	  et	  al.,	  
who	  only	  included	  MoHXLPE	  and	  therefore,	  the	  resulting	  RR	  of	  
revision	  for	  MoM	  THA	  in	  study	  II	  may	  be	  smaller	  than	  in	  the	  study	  
by	  Furnes	  et	  al.	  
	   The	  causes	  of	  revision	  were	  examined	  in	  study	  II,	  and	  MoM	  
had	  a	  higher	  RR	  of	  revision	  due	  to	  aseptic	  loosening	  than	  MoP	  
THA.	  This	  confirmed	  the	  findings	  in	  the	  study	  based	  on	  data	  from	  
the	  NJR	  by	  Smith	  et	  al.107	  Lombardi	  et	  al.	  published	  a	  study	  from	  a	  
single	  institution	  including	  1,440	  MoM	  THAs	  with	  mean	  follow-­‐up	  
of	  seven	  years.	  The	  12-­‐year	  survival	  rate	  was	  87%	  (95%	  CI:	  84-­‐90),	  
and	  the	  two	  most	  common	  indications	  for	  revision	  were	  ARMD	  
(48%;	  47	  of	  108	  hips	  revised)	  and	  aseptic	  loosening	  or	  failure	  of	  
ingrowth	  (31%;	  34	  of	  108).198	  According	  to	  the	  NJR,	  the	  highest	  
patient-­‐time	  incidence-­‐rates	  for	  specific	  causes	  of	  revision	  was	  
found	  for	  MoM	  THA	  revised	  for	  adverse	  soft	  tissue	  reaction	  to	  
particulate	  debris.194	  However,	  in	  the	  NARA	  database	  it	  was	  not	  
possible	  to	  register	  the	  cause	  of	  revision	  as	  due	  to	  adverse	  soft	  
tissue	  reaction	  to	  particulate	  debris	  or	  metal-­‐related	  pathology.	  
	   The	  discrepancies	  between	  registries	  may	  reflect	  national	  
variations	  in	  the	  use	  of	  or	  reluctance	  to	  use	  MoM	  bearings,	  
indications	  for	  primary	  surgery	  and	  revisions,	  different	  implant	  
designs,	  and	  selection	  of	  patients.	  
	  
Patient-­‐reported	  outcomes	  
PROs	  may	  be	  influenced	  by	  a	  number	  of	  factors.	  Preoperative	  
selection	  of	  patients	  for	  specific	  bearings	  may	  be,	  among	  other	  
factors,	  related	  to	  the	  activity	  level.	  Differences	  in	  PROs	  may	  
therefore	  possibly	  reflect	  this	  selection.	  In	  a	  study	  from	  the	  NJR	  
including	  4,596	  PROMs-­‐linked	  primary	  THAs	  with	  a	  mean	  follow-­‐up	  
of	  seven	  months,	  there	  was	  no	  difference	  in	  change	  (postoperative	  
compared	  to	  preoperative)	  for	  EQ-­‐5D	  index	  score	  between	  
patients	  having	  MoP,	  CoP,	  or	  CoC	  bearings,	  but	  there	  were	  
statistically	  significant	  differences	  in	  median	  postoperative	  EQ-­‐5D	  
index	  scores	  with	  CoC	  having	  the	  highest	  and	  CoP	  THA	  the	  lowest	  
score.195	  However,	  the	  differences	  in	  postoperative	  EQ-­‐5D	  index	  
scores	  between	  bearings	  are	  small	  (maximum	  0.052)	  and	  may	  be	  
without	  clinical	  significance,	  as	  MCII	  in	  a	  Danish	  registry	  setting	  
was	  determined	  to	  be	  0.31	  one	  year	  after	  primary	  THA134.	  Similar	  
findings	  after	  longer	  follow-­‐up	  are	  reported	  in	  study	  III,	  although	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patients	  having	  MoM	  and	  not	  CoP	  were	  included.	  In	  a	  series	  
including	  208	  consecutive,	  large-­‐diameter	  CoC	  THAs	  from	  a	  single	  
institution,	  there	  were	  143	  silent	  hips	  (69%),	  22	  (11%)	  with	  noises	  
other	  than	  squeaking,	  17	  (8%)	  with	  unreproducible	  squeaking	  and	  
26	  (13%)	  with	  reproducible	  squeaking.	  The	  HOOS	  subscales	  and	  
UCLA	  activity	  scores	  were	  compared	  for	  patients	  with	  silent	  and	  
noisy	  THAs,	  and	  no	  statistically	  significant	  difference	  was	  found	  for	  
the	  UCLA	  activity	  score,	  HOOS	  Pain,	  HOOS	  ADL,	  and	  HOOS	  QoL.	  
However,	  patients	  with	  noisy	  THA	  had	  lower	  scores	  for	  HOOS	  
Symptoms	  and	  HOOS	  Sport.112	  In	  study	  III,	  similar	  prevalence	  of	  
noises	  from	  CoC	  THA	  was	  found	  but	  except	  from	  the	  UCLA	  activity	  
score,	  significant	  lower	  scores	  for	  all	  subscales	  were	  found	  when	  
comparing	  noisy	  CoC	  to	  silent	  MoP	  THAs.	  
	  
CONCLUSION	  
The	  main	  conclusions	  of	  the	  thesis	  are:	  
	   Study	  I:	  At	  8.7	  years	  of	  follow-­‐up,	  CoC	  THA	  had	  a	  33%	  higher	  
risk	  of	  revision	  for	  any	  reason	  than	  MoP	  THA,	  but	  this	  was	  not	  
statistically	  significant.	  CoC	  THA	  had	  a	  significantly	  higher	  
incidence	  of	  revision	  due	  to	  component	  failure.	  The	  incidences	  of	  
ceramic	  head	  and	  liner	  fracture	  were	  0.28%	  and	  0.17%,	  
respectively.	  
	   Study	  II:	  A	  higher	  RR	  of	  revision	  for	  any	  reason	  at	  six-­‐year	  
follow-­‐up	  was	  found	  for	  MoM	  THA	  than	  for	  MoP	  THA,	  but	  after	  
exclusion	  of	  patients	  with	  the	  ASR	  acetabular	  component,	  the	  risk	  
of	  revision	  was	  similar	  between	  the	  two	  groups	  of	  bearings.	  At	  six-­‐
year	  follow-­‐up,	  there	  was	  a	  much	  higher	  risk	  of	  revision	  with	  
prosthetic	  design	  combinations	  of	  ASR/Summit	  and	  ASR/Corail	  
than	  for	  MoP	  THA,	  whereas	  the	  risk	  of	  revision	  was	  similar	  for	  the	  
Recap/Bi-­‐Metric	  combination	  and	  for	  MoP	  THA.	  
	   Study	  III:	  No	  significant	  difference	  in	  mean	  scores	  in	  the	  five	  
HOOS	  subscales,	  EQ-­‐5D	  index,	  EQ	  VAS,	  or	  UCLA	  activity	  score	  was	  
found	  between	  patients	  with	  CoC,	  MoM,	  and	  MoP	  THA	  after	  mean	  
follow-­‐up	  of	  6.9,	  5.1,	  and	  6.9	  years,	  respectively.	  There	  were	  
significantly	  lower	  mean	  subscale	  scores	  for	  all	  types	  of	  bearings	  
and	  subscales	  when	  comparing	  noisy	  THA	  to	  silent	  MoP	  THA,	  
except	  for	  patients	  having	  noisy	  CoC	  and	  MoM	  THA	  who	  had	  
similar	  mean	  UCLA	  activity	  scores	  as	  patients	  with	  silent	  MoP	  THA.	  
	  
FUTURE	  PERSPECTIVES	  
The	  DHR	  has	  a	  very	  high	  coverage	  and	  completeness	  and	  contains	  
well	  validated	  data	  on	  diagnosis	  for	  primary	  THA.16,117	  However,	  a	  
number	  of	  prognostic	  factors	  for	  the	  outcome	  of	  THA	  have	  not	  
been	  validated,	  thus	  further	  studies	  may	  be	  performed	  in	  order	  to	  
validate	  data	  on,	  for	  instance,	  implant	  design,	  types	  of	  bearings,	  
and	  coating	  with/without	  hydroxyapatite.	  Since	  PJI	  is	  the	  only	  
revision	  cause	  that	  has	  been	  validated118,	  future	  studies	  may	  be	  
conducted	  to	  validate	  other	  revision	  causes.	  	  
	   CoC	  and	  MoM	  bearings	  were	  introduced	  in	  order	  to	  reduce	  
problems	  related	  to	  aseptic	  loosening	  of	  MoP	  THA.	  As	  aseptic	  
loosening	  most	  commonly	  occurs	  with	  longer	  follow-­‐up,	  there	  is	  a	  
continuing	  need	  for	  large	  population-­‐based	  studies	  comparing	  
survival	  of	  THA	  with	  different	  types	  of	  bearings	  -­‐	  including	  CoP.	  
There	  are	  several	  prognostic	  factors	  for	  outcome	  in	  relation	  to	  
bearings	  that	  are	  of	  interest	  and	  deserve	  further	  investigation:	  As	  
CoC	  THA	  are	  recommended	  for	  young	  and	  active	  patients	  by	  some	  
authors167,	  the	  association	  between	  CoC	  bearings	  and	  activity	  level	  
before	  and	  after	  surgery	  should	  be	  examined	  in	  more	  detail	  in	  a	  
cohort	  study.	  For	  MoM	  THA,	  the	  association	  of	  results	  of	  
chromium	  and	  cobalt	  ion	  measurements,	  ultrasound	  
examinations,	  and	  MRIs	  may	  now	  be	  assessed	  in	  nationwide	  
population-­‐based	  cohort	  studies,	  as	  these	  variables	  are	  contained	  
in	  the	  DHR	  since	  2013.	  	  
	   When	  younger	  patients	  are	  treated	  with	  THA,	  the	  risk	  of	  more	  
than	  one	  revision	  is	  increased.	  Ceramic	  fracture	  is	  a	  specific	  
revision	  cause	  only	  related	  to	  the	  use	  of	  CoC	  bearings	  and	  in	  study	  	  
II,	  revision	  due	  to	  aseptic	  loosening	  was	  more	  frequently	  for	  MoM	  
bearings.	  Therefore,	  the	  types	  of	  bearings	  may	  be	  a	  prognostic	  
factor	  also	  for	  the	  second	  revision,	  which	  may	  call	  for	  further	  
	  
Table	  10.	  Abbrevaitions	  
ALVAL	   Aseptic	  lymphocytic	  vasculitis-­‐associated	  lesions	  
AOA	  
NJRR	  
Australian	  Orthopaedic	  Association	  National	  Joint	  
Replacement	  Registry	  
ARMD	   Adverse	  reaction	  to	  metal	  debris	  
ASR	   Articular	  Surface	  Replacement	  
ASTM	   American	  Society	  for	  Testing	  and	  Materials	  
BMI	   Body	  mass	  index	  
CCI	   Charlson	  comorbidity	  index	  
CI	   Confidence	  interval	  
CoC	   Ceramic-­‐on-­‐ceramic	  
CoP	   Ceramic-­‐on-­‐polyethylene	  
CRS	   Civil	  Registration	  System	  
CT	   Computed	  tomography	  
DHR	   Danish	  Hip	  Arthroplasty	  Registry	  
DNPR	   Danish	  National	  Patient	  Registry	  
FDA	   Food	  and	  Drug	  Administration	  
HHS	   Harris	  Hip	  Score	  
HOOS	   Hip	  disability	  and	  osteoarthritis	  outcome	  score	  
HR	   Hazard	  ratio	  
HXLPE	   Highly	  cross-­‐linked	  polyethylene	  
IQR	   Inter-­‐quartile	  range	  
LDH	   Large-­‐diameter-­‐head	  
MCII	   Minimal	  clinically	  important	  improvement	  
MeSH	   Medical	  subject	  heading	  
MoHXLPE	   Metal-­‐on-­‐highly	  cross-­‐linked	  polyethylene	  
MoM	   Metal-­‐on-­‐metal	  
MoP	   Metal-­‐on-­‐polyethylene	  
MRI	   Magnetic	  resonance	  imaging	  
NARA	   Nordic	  Arthroplasty	  Register	  Association	  
NJR	   National	  Joint	  Registry	  for	  England,	  Wales,	  Northern	  
Ireland	  and	  Isle	  of	  Man	  
OA	   Osteoarthritis	  
PASS	   Patient-­‐acceptable	  symptom	  state	  
PJI	   Prosthetic	  joint	  infection	  
PPV	   Positive	  predictive	  value	  
PRO	   Patient-­‐reported	  outcome	  
PROM	   Patient-­‐reported	  outcome	  
QoL	   Quality	  of	  life	  
RCT	   Randomized	  clinical	  trial	  
ROM	   Range	  of	  motion	  
RR	   Relative	  risk	  
SHAR	   Swedish	  Hip	  Arthroplasty	  Register	  
THA	   Total	  hip	  arthroplasty	  
UCLA	   University	  of	  California,	  Los	  Angeles	  
UHMWPE	   Ultrahigh-­‐molecular-­‐weight	  polyethylene	  
VAS	   Visual	  analogue	  scale	  
WOMAC	   Western	  Ontario	  and	  McMaster	  Universities	  
Osteoarthritis	  Index	  
Y-­‐TZP	   Yttria	  stabalized	  tetragonal	  zirconia	  polycrystals	  
ZTA	   Zirconia-­‐toughened	  alumina	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investigation.	  	  
	   Although	  the	  treatment	  with	  THA	  is	  successful,	  not	  all	  
patients	  will	  have	  their	  expectations	  fulfilled	  or	  be	  satisfied	  after	  
THA.	  Therefore,	  patient	  selection	  for	  surgery	  is	  very	  important	  and	  
may	  be	  influenced	  by	  many	  factors,	  which	  together	  result	  in	  a	  
patient’s	  risk	  profile	  in	  relation	  to	  the	  outcome	  after	  THA.	  PROMs	  
may	  be	  very	  useful	  to	  identify	  this	  risk	  profile,	  and	  PROMs	  should	  
be	  incorporated	  more	  systematically	  in	  the	  DHR.	  
	  
SUMMARY	  
Total	  hip	  arthroplasty	  (THA)	  is	  a	  common	  and	  successful	  treatment	  
of	  patients	  suffering	  from	  severe	  osteoarthritis	  that	  significantly	  
reduces	  pain	  and	  improves	  hip	  function	  and	  quality	  of	  life.	  
Traditionally,	  the	  outcome	  of	  THA	  has	  been	  evaluated	  by	  
orthopaedic	  surgeons	  and	  assessed	  in	  morbidity	  and	  mortality	  
rates,	  and	  implant	  survival.	  As	  patients	  and	  surgeons	  may	  assess	  
outcome	  after	  THA	  differently,	  patient-­‐reported	  outcomes	  (PROs)	  
have	  gained	  much	  more	  interest	  and	  are	  today	  recognized	  as	  very	  
important	  tools	  for	  evaluating	  the	  outcome	  and	  satisfaction	  after	  
THA.	  One	  of	  the	  prognostic	  factors	  for	  the	  outcome	  of	  THA	  is	  the	  
type	  of	  bearings.	  This	  PhD	  thesis	  focuses	  on	  the	  influence	  of	  
different	  types	  of	  bearings	  on	  implant	  survival,	  revision	  causes,	  
PROs,	  and	  noises	  from	  THA.	  
	   The	  aims	  of	  the	  thesis	  were:	  	  
	   Study	  I:	  To	  examine	  the	  revision	  risk	  and	  to	  investigate	  the	  
causes	  of	  revision	  of	  cementless	  ceramic-­‐on-­‐ceramic	  (CoC)	  THAs	  
comparing	  them	  to	  those	  of	  “standard”	  metal-­‐on-­‐polyethylene	  
(MoP)	  THAs.	  
	   Study	  II:	  To	  compare	  the	  six-­‐year	  revision	  risk	  for	  metal-­‐on-­‐
metal	  (MoM)	  with	  that	  for	  MoP	  bearings	  in	  cementless	  stemmed	  
THA,	  and	  further	  to	  study	  the	  revision	  risk	  for	  different	  designs	  of	  
stemmed	  MoM	  THAs	  and	  the	  causes	  of	  revision.	  
	   Study	  III:	  To	  examine	  the	  association	  between	  CoC,	  MoM,	  and	  
MoP	  bearings	  and	  both	  generic	  and	  disease-­‐specific	  PROMs,	  and	  
furthermore	  to	  examine	  the	  incidence	  and	  types	  of	  noises	  from	  
the	  three	  types	  of	  bearings	  and	  identify	  the	  effect	  of	  noises	  on	  
PROM	  scores.	  
	   In	  study	  I	  and	  III,	  we	  used	  data	  from	  the	  Danish	  Hip	  
Arthroplasty	  Registry	  combined	  with	  data	  from	  the	  Civil	  
Registration	  System	  and	  the	  Danish	  National	  Patient	  Registry.	  In	  
study	  II,	  data	  from	  the	  Nordic	  Arthroplasty	  Register	  Association,	  
containing	  data	  from	  hip	  arthroplasty	  registries	  in	  Denmark,	  
Norway,	  Sweden,	  and	  Finland,	  was	  used.	  
	   In	  study	  I,	  11,096	  patients	  operated	  from	  2002	  through	  2009	  
with	  cementless	  THA	  were	  included.	  Of	  these,	  16%	  had	  CoC	  THA	  
and	  84%	  had	  MoP	  THA.	  At	  8.7-­‐year	  follow-­‐up,	  no	  difference	  in	  RR	  
of	  revision	  for	  any	  cause	  was	  found	  for	  CoC	  compared	  to	  MoP	  
THA.	  One	  cause	  of	  revision	  related	  only	  to	  CoC	  THA	  is	  ceramic	  
fracture.	  Medical	  records	  were	  reviewed	  for	  patients	  who	  had	  
revision	  surgery	  due	  to	  component	  failure,	  and	  six	  patients	  (0,34%)	  
had	  been	  revised	  due	  to	  ceramic	  fracture.	  No	  other	  difference	  in	  
prevalence	  of	  causes	  of	  revision	  was	  found	  when	  comparing	  CoC	  
to	  MoP	  THA.	  
	   Study	  II	  included	  32,678	  patients	  who	  were	  operated	  from	  
2002	  through	  2010	  with	  cementless	  stemmed	  THA	  with	  either	  
MoM	  bearings	  (11,567	  patients,	  35%)	  or	  MoP	  bearings	  (21,111	  
patients,	  65%).	  At	  six-­‐year	  follow-­‐up,	  the	  RR	  of	  revision	  for	  any	  
cause	  was	  significantly	  higher	  for	  MoM	  compared	  to	  MoP	  THA.	  
When	  comparing	  different	  combinations	  of	  cup/stem	  with	  MoM	  to	  
MoP	  bearings,	  there	  was	  an	  increased	  RR	  of	  revision	  for	  any	  cause	  
for	  the	  ASR/Summit,	  ASR/Corail,	  and	  “other”	  combinations.	  There	  
was	  a	  higher	  prevalence	  of	  revision	  due	  to	  aseptic	  loosening	  for	  
MoM	  compared	  to	  MoP	  THA.	  In	  contrast,	  the	  prevalence	  of	  
revision	  due	  to	  dislocation	  was	  lower	  for	  MoM	  THA.	  
	   In	  study	  III,	  a	  set	  of	  questionnaires	  including	  HOOS,	  EQ-­‐5D,	  
UCLA	  activity	  score,	  and	  a	  questionnaire	  about	  noises	  from	  the	  
THA	  was	  send	  to	  patients	  having	  THA	  with	  CoC,	  MoM,	  or	  MoP	  
bearings.	  The	  response	  rate	  was	  85%	  and	  among	  the	  3,089	  
patients	  responding,	  45%	  received	  CoC,	  17%	  MoM,	  and	  38%	  MoP	  
THA.	  No	  differences	  in	  mean	  subscale	  scores	  were	  found	  for	  CoC	  
and	  MoM	  compared	  to	  MoP	  THA,	  except	  for	  CoC	  THA	  that	  had	  a	  
lower	  mean	  HOOS	  Symptoms	  score	  than	  MoP	  THA.	  27%	  of	  
patients	  with	  CoC,	  29%	  of	  patients	  with	  MoM,	  and	  12%	  of	  patients	  
with	  MoP	  bearings	  had	  experienced	  noises	  from	  the	  THA.	  For	  the	  
three	  types	  of	  bearings,	  PROM	  scores	  from	  patients	  with	  noisy	  
THA	  were	  significantly	  lower	  when	  compared	  to	  silent	  MoP	  THA,	  
except	  for	  noisy	  CoC	  and	  MoM	  THA	  that	  had	  the	  same	  mean	  UCLA	  
activity	  score	  as	  silent	  MoP	  THA.	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